Caly - calcyon neuron-specific vesicular protein Gene
Also Known as Drd1ip; Calcyon
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 192349
Summary
Predicted to enable clathrin light chain binding activity. Involved in anterograde axonal transport; positive regulation of clathrin coat assembly; and positive regulation of retrograde axon cargo transport. Located in axon. Biomarker of attention deficit hyperactivity disorder. Human ortholog(s) of this gene implicated in attention deficit hyperactivity disorder. Orthologous to human CALY (calcyon neuron specific vesicular protein). [provided by Alliance of Genome Resources, Apr 2022]
Caly Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001190399.1 | NP_001177328.1 | neuron-specific vesicular protein calcyon |
| NM_138915.1 | NP_620270.1 | neuron-specific vesicular protein calcyon |
Gene Ontology
- Molecular Function
- Biological Process
- Cellular Component
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein-containing complex binding |
IPI
IPI: Inferred from physical interaction
|
22843680 | RGD |
| Biological Process GO Annotation | Evidence | References | Source |
|---|---|---|---|
| involved in anterograde axonal transport |
IMP
IMP: Inferred from mutant phenotype
|
29949458 | RGD |
| involved in positive regulation of clathrin coat assembly |
IDA
IDA: Inferred from direct assay
|
16595675 | RGD |
| involved in positive regulation of retrograde axon cargo transport |
IMP
IMP: Inferred from mutant phenotype
|
29949458 | RGD |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in axon |
IDA
IDA: Inferred from direct assay
|
29949458 | RGD |
EXP: Inferred from Experiment
IDA: Inferred from direct assay
IPI: Inferred from physical interaction
IMP: Inferred from mutant phenotype
IGI: Inferred from genetic interaction
IEP: Inferred from expression pattern
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
neuron-specific vesicular protein calcyon |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(102)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0470 | Neomycin sulfate | Inhibitor | 99.92% | Unkown |
| HY-N0215 | L-Phenylalanine | Antagonist | 99.98% | Unkown |
| HY-10341 | Fasudil Hydrochloride | 99.97% | Yes | |
| HY-A0057 | Gabapentin | Inhibitor | 99.99% | Yes |
| HY-B0246 | Carbamazepine | 99.90% | Yes | |
| HY-B0782 | Acetazolamide | 99.85% | Yes | |
| HY-13764 | Tetrandrine | Inhibitor | 99.90% | Yes |
| HY-B0561 | Spironolactone | 99.81% | Yes | |
| HY-B0193A | Prazosin hydrochloride | 99.89% | Unkown | |
| HY-12542 | Dantrolene | Inhibitor | 99.93% | Yes |
| HY-75161 | (-)-Menthol | Activator | 99.79% | Unkown |
| HY-70037 | Cinacalcet | Agonist | 99.93% | Yes |
| HY-111964 | Lenacapavir | Inhibitor | 98.44% | Unkown |
| HY-B1193 | Terfenadine | 99.98% | Unkown | |
| HY-B1077 | Penfluridol | 99.93% | Unkown | |
| HY-B0632 | Diltiazem | Inhibitor | 99.70% | Yes |
| HY-B1221 | Flufenamic acid | 99.98% | Unkown | |
| HY-17404 | Cilnidipine | Inhibitor | 99.89% | Yes |
| HY-10341A | Fasudil | 99.98% | Yes | |
| HY-14603 | Clioquinol | 99.84% | Unkown | |
| HY-70037A | Cinacalcet hydrochloride | Agonist | 99.98% | Yes |
| HY-14656 | Diltiazem hydrochloride | Antagonist | 99.47% | Yes |
| HY-N1370 | Tanshinone IIA sulfonate sodium | Inhibitor | 99.77% | Unkown |
| HY-B0588 | Brinzolamide | Inhibitor | 99.91% | Unkown |
| HY-B0782A | Acetazolamide sodium | 99.54% | Yes | |
| HY-B1546A | Benzamil hydrochloride | Inhibitor | 99.70% | Unkown |
| HY-75839 | Dronedarone Hydrochloride | 99.99% | Unkown | |
| HY-15553A | Mibefradil dihydrochloride | Inhibitor | 99.71% | Yes |
| HY-12542A | Dantrolene sodium hemiheptahydrate | Inhibitor | 99.79% | Unkown |
| HY-A0057A | Gabapentin hydrochloride | Inhibitor | 98.0% | Yes |
| HY-B0109A | Dorzolamide hydrochloride | Inhibitor | 99.86% | Yes |
| HY-10932 | Aniracetam | Modulator | 99.94% | Unkown |
| HY-A0079 | Tetracaine | 99.87% | Unkown | |
| HY-B1693 | Levomepromazine | 99.98% | Unkown | |
| HY-B0358A | Flunarizine dihydrochloride | 99.90% | Yes | |
| HY-B0596 | Taltirelin | 99.91% | Unkown | |
| HY-14657 | Dantrolene sodium | Inhibitor | 99.79% | Yes |
| HY-B0358 | Flunarizine | 99.79% | Yes | |
| HY-B1424 | Benzthiazide | Inhibitor | 99.70% | Unkown |
| HY-B0684 | Iopamidol | 99.85% | Unkown | |
| HY-A0082 | Diphenidol hydrochloride | Antagonist | 99.06% | Unkown |
| HY-N0215R | L-Phenylalanine (Standard) | Antagonist | 99.99% | Unkown |
| HY-16952A | Bepridil hydrochloride hydrate | Antagonist | 99.86% | Unkown |
| HY-B1154 | Penbutolol sulfate | Antagonist | 98.89% | Unkown |
| HY-B0473 | Tetracaine hydrochloride | Inhibitor | 99.91% | Unkown |
| HY-B0021 | Doxifluridine | Inhibitor | 99.44% | Unkown |
| HY-B0246R | Carbamazepine (Standard) | 99.97% | Unkown | |
| HY-Y0258 | Benzocaine | 99.98% | Unkown | |
| HY-B0551 | Doxapram | Inhibitor | 99.70% | Unkown |
| HY-Z0478 | (-)-Limonene | Inhibitor | 99.42% | Unkown |
| HY-103370 | Talniflumate | Inhibitor | 99.90% | Yes |
| HY-B0380 | Trimebutine | 99.42% | Yes | |
| HY-107929 | Calcium polystyrene sulfonate | / | Unkown | |
| HY-B0380A | Trimebutine maleate | 99.66% | Yes | |
| HY-W042301 | Xipamide | 99.74% | Unkown | |
| HY-Y0258A | Benzocaine (hydrochloride) | Modulator | 99.83% | Unkown |
| HY-B0549A | Flavoxate hydrochloride | 99.70% | Yes | |
| HY-107319 | Almitrine mesylate | Inhibitor | 98.88% | Unkown |
| HY-B0551A | Doxapram hydrochloride hydrate | Inhibitor | 99.28% | Unkown |
| HY-109056 | Elsulfavirine | Inhibitor | 99.90% | Unkown |
| HY-121235 | Clonixin | Inhibitor | 98.88% | Unkown |
| HY-U00212 | Aranidipine | Antagonist | 99.12% | Unkown |
| HY-17613 | Evocalcet | Activator | 99.28% | Unkown |
| HY-121186 | Bevantolol hydrochloride | Antagonist | 98.98% | Yes |
| HY-109545 | Isopropyl unoprostone | Activator | 98.42% | Unkown |
| HY-16216 | Gabapentin enacarbil | Inhibitor | 99.90% | Yes |
| HY-111964A | Lenacapavir sodium | Inhibitor | 99.86% | Unkown |
| HY-112961 | Patiromer | Inhibitor | 95.0% | Unkown |
| HY-128370 | Calcium trinatrium diethylenetriaminepentaacetic acid hydrate | Inhibitor | 98.0% | Unkown |
| HY-A0135 | Enflurane | Inhibitor | 98.0% | Unkown |
| HY-A0236 | Aprindine | Inhibitor | 98.43% | Unkown |
| HY-B0562 | Methyclothiazide | 99.49% | Unkown | |
| HY-B0596A | Taltirelin acetate | 99.75% | Unkown | |
| HY-P1769 | Angiotensin II (5-8), human | 99.74% | Unkown | |
| HY-109106A | Upacicalcet sodium | Agonist | 99.91% | Unkown |
| HY-B0549 | Flavoxate | 98.07% | Yes | |
| HY-10341C | Fasudil dihydrochloride | 99.98% | Yes | |
| HY-116790 | (-)-Penbutolol | Antagonist | 99.74% | Unkown |
| HY-B1471 | Fluorometholone acetate | Inhibitor | 98.54% | Unkown |
| HY-15553 | Mibefradil | Inhibitor | / | Unkown |
| HY-B0109 | Dorzolamide | Inhibitor | / | Unkown |
| HY-109106 | Upacicalcet | Agonist | / | Unkown |
| HY-150520 | Neomycin | Inhibitor | / | Unkown |
| HY-10341B | Fasudil hydrochloride semihydrate | / | Unkown | |
| HY-106916 | Unoprostone | Activator | 99.0% | Unkown |
| HY-121166 | Levobetaxolol | Antagonist | / | Unkown |
| HY-14656R | Diltiazem hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-75839R | Dronedarone Hydrochloride (Standard) | / | Unkown | |
| HY-A0270 | Diphenidol | Antagonist | / | Unkown |
| HY-B0021R | Doxifluridine (Standard) | Inhibitor | / | Unkown |
| HY-B0109AR | Dorzolamide hydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-B0193AR | Prazosin hydrochloride (Standard) | / | Unkown | |
| HY-B0401A | Tolbutamide sodium | Inducer | / | Unkown |
| HY-B0588A | Brinzolamide hydrochloride | Inhibitor | / | Unkown |
| HY-B0588R | Brinzolamide (Standard) | Inhibitor | / | Unkown |
| HY-B1546 | Benzamil | Inhibitor | / | Unkown |
| HY-B1558 | Bifemelane | / | Unkown | |
| HY-P1792 | Angiotensin II (1-4), human | Agonist | / | Unkown |
| HY-P1792A | Angiotensin II (1-4), human TFA | Agonist | / | Unkown |
| HY-121235R | Clonixin (Standard) | Inhibitor | / | Unkown |
| HY-B1693R | Levomepromazine (Standard) | / | Unkown | |
| HY-Y0258AR | Benzocaine (hydrochloride) (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(77)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-N6687 | Calcimycin | 99.12% | Phase 4 | |
| HY-100560 | Abscisic acid | 99.78% | Phase 4 | |
| HY-W170020 | PTCA | Ligand | 99.72% | Phase 4 |
| HY-153306 | Zovegalisib | Inhibitor | 98.80% | Phase 3 |
| HY-13898 | Taselisib | Inhibitor | 99.75% | Phase 3 |
| HY-50694 | Senicapoc | Inhibitor | 99.91% | Phase 3 |
| HY-P0033 | Argireline | Inhibitor | 99.86% | Phase 3 |
| HY-115864 | Osavampator | Activator | 99.74% | Phase 3 |
| HY-Y0413 | Biacetyl monoxime | Inhibitor | 98.0% | Phase 3 |
| HY-15724 | Vercirnon | Antagonist | 98.01% | Phase 3 |
| HY-10805A | Almorexant hydrochloride | 99.98% | Phase 3 | |
| HY-106449 | Recoflavone | 98.0% | Phase 3 | |
| HY-14797 | Ombrabulin | Inhibitor | 98.53% | Phase 3 |
| HY-121872 | DP-b99 | Inhibitor | 95.0% | Phase 3 |
| HY-145567 | Fasedienol | 99.68% | Phase 3 | |
| HY-Z7721 | (Rac)-Beraprost sodium | Inhibitor | 99.0% | Phase 3 |
| HY-106837 | Israpafant | Antagonist | / | Phase 3 |
| HY-113970 | Nebracetam | / | Phase 3 | |
| HY-15855 | Fosbretabulin tromethamine | Modulator | / | Phase 3 |
| HY-B1693A | Levomepromazine hydrochloride | / | Phase 3 | |
| HY-P5796 | FS-2 | Inhibitor | / | Phase 3 |
| HY-118962 | E913 | / | Phase 3 | |
| HY-50876 | Daporinad | 99.91% | Phase 2 | |
| HY-N1584 | Halofuginone | 99.28% | Phase 2 | |
| HY-13513 | U-104 | Inhibitor | 99.95% | Phase 2 |
| HY-101064 | Fmoc-leucine | 99.91% | Phase 2 | |
| HY-10007 | NPS-2143 | Antagonist | 99.94% | Phase 2 |
| HY-116330A | Hyperforin dicyclohexylammonium salt | 99.48% | Phase 2 | |
| HY-10167A | Tecalcet Hydrochloride | Modulator | 99.43% | Phase 2 |
| HY-160023 | Elisrasib | 99.68% | Phase 2 | |
| HY-10066 | Nelivaptan | Antagonist | 99.89% | Phase 2 |
| HY-118467 | Benzolamide | Inhibitor | 99.59% | Phase 2 |
| HY-100414 | Soraprazan | Inhibitor | 99.78% | Phase 2 |
| HY-B0340 | Nefiracetam | Activator | 99.87% | Phase 2 |
| HY-119850 | Aladorian | Modulator | 99.55% | Phase 2 |
| HY-N0842 | Bevirimat | Inhibitor | 99.82% | Phase 2 |
| HY-135891 | AZD2423 | Antagonist | 99.91% | Phase 2 |
| HY-100779 | Rimacalib | Inhibitor | 99.14% | Phase 2 |
| HY-100298 | Caldaret | Inhibitor | 98.35% | Phase 2 |
| HY-100934 | SC-9 | Activator | 99.33% | Phase 2 |
| HY-137459A | Vocacapsaicin hydrochloride | Antagonist | 95.66% | Phase 2 |
| HY-147384 | CXL-1020 | ≥99.0% | Phase 2 | |
| HY-10049 | CP 122721 | Antagonist | / | Phase 2 |
| HY-105269A | Org 30029 hydrochloride | Activator | / | Phase 2 |
| HY-106904 | Nexopamil | Antagonist | / | Phase 2 |
| HY-110312 | JTV-519 fumarate | / | Phase 2 | |
| HY-113037B | Farnesyl pyrophosphate | Agonist | / | Phase 2 |
| HY-121535 | Levosemotiadil | Inhibitor | / | Phase 2 |
| HY-12596 | JNJ-26489112 | 99.31% | Phase 2 | |
| HY-169115 | PD-0299685 | / | Phase 2 | |
| HY-19397 | BMS-223131 | / | Phase 2 | |
| HY-W565924 | STX107 | / | Phase 2 | |
| HY-101616 | ABT-639 hydrochloride | Inhibitor | / | Phase 2 |
| HY-106415 | Terflavoxate | Antagonist | / | Phase 2 |
| HY-106927 | Bay Y5959 | Agonist | / | Phase 2 |
| HY-114826S | Prostaglandin E2-1-glyceryl ester-d5 | Activator | / | Phase 2 |
| HY-147301B | Resomelagon methanesulfonate | Agonist | / | Phase 2 |
| HY-108496 | Sphingosine-1-phosphate | Agonist | 99.94% | Phase 1 |
| HY-100973A | Adenosine 5′-diphosphoribose sodium | 99.47% | Phase 1 | |
| HY-101093 | CA-170 | Inhibitor | 99.39% | Phase 1 |
| HY-16935 | Mavatrep | Antagonist | 99.67% | Phase 1 |
| HY-100886 | BAY1082439 | 99.35% | Phase 1 | |
| HY-107111 | GSK1034702 | Agonist | 99.78% | Phase 1 |
| HY-NP009 | α-Lactalbumin | Inhibitor | 99.9% | Phase 1 |
| HY-126077 | MTI-31 | Inhibitor | 99.92% | Phase 1 |
| HY-129851 | NTP42 | Antagonist | 98.58% | Phase 1 |
| HY-120588 | BI 639667 | Antagonist | 98.87% | Phase 1 |
| HY-P4160 | PDC31 | Inhibitor | 98.67% | Phase 1 |
| HY-115681 | (2R/S)-6-PNG | Inhibitor | 99.96% | Phase 1 |
| HY-133011 | nAChR agonist 1 | Agonist | 98.35% | Phase 1 |
| HY-13699 | NBI-42902 | 98.65% | Phase 1 | |
| HY-114793 | AL-12180 | Agonist | / | Phase 1 |
| HY-118148 | UK-66914 | Inhibitor | / | Phase 1 |
| HY-147383 | NS-8 | Activator | / | Phase 1 |
| HY-165492 | Opc 14117 | Inhibitor | / | Phase 1 |
| HY-121701 | SR33805 analog | Antagonist | / | Phase 1 |
| HY-19062 | SM-6586 | / | Phase 1 |
Inhibitory Antibodies
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99409 | Oregovomab | 99.66% | Phase 3 | |
| HY-P991646 | ING-1 | 99.0% | Phase 1 | |
| HY-P991887 | CA9hu-1 | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(1083)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-18723 | Yoda 1 | 99.97% | Unkown | |
| HY-13434 | Ionomycin | 99.27% | Unkown | |
| HY-13433 | Thapsigargin | 99.95% | Unkown | |
| HY-100545 | BAPTA-AM | Inhibitor | 99.68% | Unkown |
| HY-112879 | Mito-TEMPO | 99.19% | Unkown | |
| HY-101896 | Fluo-4 AM | 99.84% | Unkown | |
| HY-W009724 | 2-Aminoethyl diphenylborinate | 98.86% | Unkown | |
| HY-D0989 | Rhod-2 AM | ≥97.0% | Unkown | |
| HY-D0861 | EGTA | 99.89% | Unkown | |
| HY-100202 | TPEN | 99.91% | Unkown | |
| HY-N0219 | Bicuculline | Antagonist | 99.98% | Unkown |
| HY-13434A | Ionomycin calcium | 98.32% | Unkown | |
| HY-19608 | GSK1016790A | 99.93% | Unkown | |
| HY-100350 | CA-074 methyl ester | Inhibitor | 99.81% | Unkown |
| HY-100168 | BAPTA | Inhibitor | 98.04% | Unkown |
| HY-15084B | Dizocilpine | Antagonist | 99.95% | Unkown |
| HY-126010 | Dooku1 | Antagonist | 99.90% | Unkown |
| HY-103350 | CA-074 | Inhibitor | 99.94% | Unkown |
| HY-10588 | Bay K 8644 | Agonist | 99.96% | Unkown |
| HY-19805 | STO-609 | Inhibitor | 98.20% | Unkown |
| HY-100831 | YM-58483 | Inhibitor | 99.38% | Unkown |
| HY-P0221 | PACAP (1-38), human, ovine, rat | Inducer | 99.99% | Unkown |
| HY-12323 | ISX-9 | Activator | 99.76% | Unkown |
| HY-D1024 | Coelenterazine h | 99.41% | Unkown | |
| HY-138620 | MCU-i4 | Inhibitor | 99.94% | Unkown |
| HY-101455 | CDN1163 | Activator | 99.90% | Unkown |
| HY-119287 | TSQ | 99.50% | Unkown | |
| HY-118630 | Vacuolin-1 | Inhibitor | 98.54% | Unkown |
| HY-100912 | W-7 hydrochloride | 99.96% | Unkown | |
| HY-101379A | 8-Bromo-cGMP sodium | Inhibitor | 99.89% | Unkown |
| HY-103312 | Xestospongin C | Inhibitor | 99.9% | Unkown |
| HY-P1410B | D-GsMTx4 | Inhibitor | 99.44% | Unkown |
| HY-123071 | Box5 | Antagonist | 98.81% | Unkown |
| HY-134923 | CA77.1 | Inducer | 99.92% | Unkown |
| HY-Y0669 | Pipecolic acid | Inhibitor | 99.92% | Unkown |
| HY-15754 | CGP37157 | Inhibitor | 99.87% | Unkown |
| HY-D1498 | Mag-Fluo-4 AM | ≥96.0% | Unkown | |
| HY-D0973 | EGTA-AM | 99.81% | Unkown | |
| HY-W019981B | Magnesium chloride hexahydrate, for molecular biology | Activator | 99.40% | Unkown |
| HY-103319 | Calmidazolium chloride | Antagonist | 99.94% | Unkown |
| HY-100973 | Adenosine 5′-diphosphoribose | 98.21% | Unkown | |
| HY-N6732 | K-252a | Inhibitor | 99.45% | Unkown |
| HY-101897 | Fura-2 AM | ≥99.0% | Unkown | |
| HY-P0256 | Apamin | Inhibitor | 99.96% | Unkown |
| HY-P5912 | GluN1(356-385) | Inhibitor | 99.95% | Unkown |
| HY-N0215S12 | L-Phenylalanine-d5 | Antagonist | 99.90% | Unkown |
| HY-50722 | NNC 55-0396 | Inhibitor | 98.43% | Unkown |
| HY-15515 | SEA0400 | Inhibitor | 99.95% | Unkown |
| HY-D0716 | Fluo-3AM | ≥99.0% | Unkown | |
| HY-103474 | Bicuculline methiodide | Inhibitor | 99.93% | Unkown |
| HY-120691A | GSK205 | Antagonist | 99.47% | Unkown |
| HY-107859 | Tris(2-chloroethyl) phosphate | 97.07% | Unkown | |
| HY-101044 | PPADS tetrasodium | 99.90% | Unkown | |
| HY-113037C | Farnesyl pyrophosphate ammonium | Agonist | 95.39% | Unkown |
| HY-N1502 | Carboxyatractyloside tripotassium | 99.97% | Unkown | |
| HY-15124 | (S)-(-)-Bay-K-8644 | Agonist | 99.22% | Unkown |
| HY-P10798A | Eloralintide sodium | Inhibitor | 99.92% | Unkown |
| HY-108465 | Pyr3 | Inhibitor | 99.83% | Unkown |
| HY-131614 | TPC2-A1-N | Inhibitor | 99.86% | Unkown |
| HY-107543 | 8-pCPT-2′-O-Me-cAMP sodium | Activator | 99.81% | Unkown |
| HY-W019981C | Magnesium chloride hexahydrate, for cell culture | Activator | / | Unkown |
| HY-10805 | Almorexant | 99.96% | Unkown | |
| HY-110105 | NS8593 hydrochloride | Inhibitor | 99.76% | Unkown |
| HY-N6778 | Paxilline | Inhibitor | 99.91% | Unkown |
| HY-P1410C | D-GsMTx4 TFA | Inhibitor | 99.89% | Unkown |
| HY-P3419 | PAMP-12 (unmodified) | 99.40% | Unkown | |
| HY-W127512 | 5β-Cholanic acid | 99.87% | Unkown | |
| HY-116522 | AR420626 | 98.40% | Unkown | |
| HY-108599 | DCP-LA | 98.0% | Unkown | |
| HY-I0096 | Indole-2-carboxylic acid | 99.86% | Unkown | |
| HY-113328 | Aminoadipic acid | 99.94% | Unkown | |
| HY-N6789 | KT5720 | Inhibitor | ≥99.0% | Unkown |
| HY-103192 | MDL12330A | Inhibitor | 99.82% | Unkown |
| HY-101906 | DC260126 | 99.57% | Unkown | |
| HY-107411 | Bromoenol lactone | Inhibitor | 99.59% | Unkown |
| HY-135897 | Urolithin C | 98.00% | Unkown | |
| HY-N1584A | Halofuginone hydrobromide | 99.85% | Yes | |
| HY-16697 | CID 16020046 | Antagonist | 99.81% | Unkown |
| HY-N0043 | Ginsenoside Rd | Inhibitor | 99.88% | Unkown |
| HY-125944 | MitoTEMPO hydrate | 98.03% | Unkown | |
| HY-N0215S8 | L-Phenylalanine-13C6 | Antagonist | 99.87% | Unkown |
| HY-33299 | Serpin B9-IN-1 | 97.42% | Unkown | |
| HY-133168 | Englerin A | Activator | 99.50% | Unkown |
| HY-P5712 | Gramicidin S | Inhibitor | 99.89% | Unkown |
| HY-116429 | Maresin 1 | Inhibitor | 99.03% | Unkown |
| HY-15416 | NS309 | Activator | 99.09% | Unkown |
| HY-12949 | ML204 | Inhibitor | 98.45% | Unkown |
| HY-P6292A | KS-133 TFA | Antagonist | 98.95% | Unkown |
| HY-B2149 | Quadrol | Activator | 99.96% | Unkown |
| HY-101017 | Palmitoylcarnitine chloride | 98.0% | Unkown | |
| HY-103660 | 18:0 LYSO-PE | 99.0% | Unkown | |
| HY-111208 | CCT129957 | Inhibitor | 99.16% | Unkown |
| HY-N2522 | Carboxyatractyloside dipotassium | 99.57% | Unkown | |
| HY-131648 | 1-Oleoyl-2-acetyl-sn-glycerol | Activator | 99.90% | Unkown |
| HY-W194810 | MCU-i11 | 98.05% | Unkown | |
| HY-W048457 | Palladium hydroxide on activated carbon(20%)(wetted with ca. 55% Water) | Control | ≥97.0% | Unkown |
| HY-13103 | NS 11021 | Activator | 99.51% | Unkown |
| HY-149662 | TMDJ-035 | Inhibitor | 99.92% | Unkown |
| HY-162501 | Yaddle1 | Agonist | 99.98% | Unkown |
| HY-P0190 | Iberiotoxin | Inhibitor | 99.71% | Unkown |
| HY-114252 | Strophanthidin | Inhibitor | 98.71% | Unkown |
| HY-123071A | Box5 TFA | Antagonist | 99.50% | Unkown |
| HY-15415 | KB-R7943 mesylate | Inhibitor | 99.16% | Unkown |
| HY-Y1667 | 2,6-Dibromophenol | Inhibitor | 99.76% | Unkown |
| HY-100168B | BAPTA tetrapotassium | Inhibitor | 99.42% | Unkown |
| HY-103306 | Ryanodine | 99.91% | Unkown | |
| HY-14229 | TGR5 Receptor Agonist | Agonist | 99.67% | Unkown |
| HY-120261 | GB-88 | Inhibitor | 98.66% | Unkown |
| HY-121119 | MRS 1523 | 99.97% | Unkown | |
| HY-P1080A | ω-Agatoxin IVA TFA | Inhibitor | 99.52% | Unkown |
| HY-N0515 | Ophiopogonin D | 99.80% | Unkown | |
| HY-N0601 | Ginsenoside Rf | Inhibitor | 99.48% | Unkown |
| HY-107582 | JW480 | Inhibitor | 99.82% | Unkown |
| HY-119401 | CAY10444 | Antagonist | 98.0% | Unkown |
| HY-162426 | UNC-CA2-103 | Inhibitor | 99.26% | Unkown |
| HY-P1345A | TLQP-21 TFA | Agonist | 99.90% | Unkown |
| HY-100168A | BAPTA tetrasodium | Inhibitor | 99.70% | Unkown |
| HY-P3278 | Caloxin 2A1 | Inhibitor | 99.97% | Unkown |
| HY-D0861A | EGTA tetrasodium | 99.93% | Unkown | |
| HY-103307 | FPL64176 | Agonist | 99.86% | Unkown |
| HY-107658 | SN 6 | Inhibitor | 99.66% | Unkown |
| HY-N0607 | Ginsenoside Ro | 99.81% | Unkown | |
| HY-W017387 | Sodium α-ketoisocaproate | 98.0% | Unkown | |
| HY-157562 | DS68591889 | 99.18% | Unkown | |
| HY-12496 | NS-1619 | 98.06% | Unkown | |
| HY-137790 | Bicuculline methochloride | Antagonist | 99.80% | Unkown |
| HY-15292 | S107 | Ligand | 99.77% | Unkown |
| HY-B0006C | (R)-Carvedilol | Inhibitor | 98.78% | Unkown |
| HY-D1903 | Fura Red AM | 91.00% | Unkown | |
| HY-P2847 | Urocortin II, mouse | Agonist | 99.94% | Unkown |
| HY-17449 | Fosbretabulin disodium | 99.91% | Yes | |
| HY-N15721 | Tryptophan-cholic acid | 99.75% | Unkown | |
| HY-16690 | BTS | Inhibitor | 99.79% | Unkown |
| HY-120072 | PF-3450074 | Inhibitor | 98.89% | Unkown |
| HY-136409 | N-Decanoyl-L-homoserine lactone | 98.40% | Unkown | |
| HY-10171 | NPS-2143 hydrochloride | Antagonist | 99.98% | Unkown |
| HY-106844A | (+)-EMD 57033 | 99.72% | Unkown | |
| HY-126750 | GNF362 | Inhibitor | 99.86% | Unkown |
| HY-N0663 | Talatisamine | 99.77% | Unkown | |
| HY-N2344 | Procyanidin A1 | Inhibitor | 99.96% | Unkown |
| HY-NP164 | Concanavalin A-HRP | / | Unkown | |
| HY-W011235 | Norfluoxetine hydrochloride | 99.54% | Unkown | |
| HY-128747 | α-D-Glucose-1-phosphate disodium | 99.93% | Unkown | |
| HY-16689 | VU 0240551 | Inhibitor | 99.70% | Unkown |
| HY-D1422 | ER Tracker Yellow | 96.91% | Unkown | |
| HY-19408 | Pyr10 | Inhibitor | 99.95% | Unkown |
| HY-103309 | ML218 | Inhibitor | 99.49% | Unkown |
| HY-112698 | CA-5f | 99.14% | Unkown | |
| HY-19749 | PD 151746 | Inhibitor | 95.03% | Unkown |
| HY-N0215S1 | L-Phenylalanine-d8 | Antagonist | 99.99% | Unkown |
| HY-101366 | A-61603 | Agonist | 99.34% | Unkown |
| HY-P3278A | Caloxin 2A1 TFA | Inhibitor | 99.92% | Unkown |
| HY-15293B | JTV-519 hemifumarate | Inhibitor | 99.74% | Unkown |
| HY-124416 | ML604086 | Inhibitor | 99.78% | Unkown |
| HY-160099 | 20-5,14-HEDE | 99.66% | Unkown | |
| HY-B0782R | Acetazolamide (Standard) | 99.57% | Unkown | |
| HY-N2500 | Deoxypodophyllotoxin | 99.86% | Unkown | |
| HY-P1821 | Myelin Basic Protein | 99.55% | Unkown | |
| HY-120026 | KB130015 | 98.45% | Unkown | |
| HY-16992A | W-54011 | 99.57% | Unkown | |
| HY-120597 | SAK3 | Activator | 99.80% | Unkown |
| HY-15671 | GKA50 | Activator | 99.84% | Unkown |
| HY-DY1020 | Rhod-2 AM (solution) | / | Unkown | |
| HY-N0126 | Xanthone | Inhibitor | 99.97% | Unkown |
| HY-12759 | CARM1-IN-1 | Inhibitor | 95.0% | Unkown |
| HY-120528A | GB-110 hydrochloride | Agonist | 99.86% | Unkown |
| HY-110243 | CAIX Inhibitor S4 | Inhibitor | 99.04% | Unkown |
| HY-130311 | 2-Linoleoyl glycerol | Inhibitor | 99.9% | Unkown |
| HY-103320A | Calhex 231 hydrochloride | Inhibitor | 99.81% | Unkown |
| HY-101015A | OBAA | 99.31% | Unkown | |
| HY-18071 | BI-9627 | Inhibitor | 99.71% | Unkown |
| HY-N0724 | Mesaconitine | Activator | 99.19% | Unkown |
| HY-N7690 | 3,5,7,3′,4′-Pentamethoxyflavone | Inhibitor | 99.69% | Unkown |
| HY-N0215S10 | L-Phenylalanine-13C9 | Antagonist | 98.09% | Unkown |
| HY-P0190A | Iberiotoxin TFA | Inhibitor | 99.43% | Unkown |
| HY-W001538 | S-Propargylcysteine | 97.0% | Unkown | |
| HY-157453 | CCR4 antagonist 4 | Antagonist | 98.92% | Unkown |
| HY-N7848 | Linoleamide | Inhibitor | 99.4% | Unkown |
| HY-101360 | 1-EBIO | Agonist | 99.96% | Unkown |
| HY-N0910 | Notoginsenoside Ft1 | 99.49% | Unkown | |
| HY-100712 | DPO-1 | Inhibitor | 98.39% | Unkown |
| HY-101329 | Anthracene-9-carboxylic acid | Inhibitor | 99.21% | Unkown |
| HY-103316A | Ned 19 | Inhibitor | 99.92% | Unkown |
| HY-115719 | NR162 | Inhibitor | 99.7% | Unkown |
| HY-14350 | AC-55541 | Agonist | 99.40% | Unkown |
| HY-15724A | Vercirnon sodium | Antagonist | 98.04% | Unkown |
| HY-N0252 | Catharanthine | Inhibitor | 99.46% | Unkown |
| HY-P1366 | des-Gln14-Ghrelin | 98.21% | Unkown | |
| HY-136460 | Calcium ionophore I | 99.6% | Unkown | |
| HY-162774A | GRP75-IN-1 dihydrochloride | Inducer | 99.75% | Unkown |
| HY-N0392 | Polygalasaponin F | 99.85% | Unkown | |
| HY-N2081 | Skimmianine | Inhibitor | 99.93% | Unkown |
| HY-N6066 | Praeruptorin E | 99.83% | Unkown | |
| HY-N8307 | Syringaresinol | 99.66% | Unkown | |
| HY-P10655 | Caloxin 1C2 | Inhibitor | 99.47% | Unkown |
| HY-W131725 | (+)-Norfenfluramine | Agonist | 98.79% | Unkown |
| HY-32933 | 4-Acetylphenylboronic acid | Inhibitor | 99.96% | Unkown |
| HY-16639 | ML314 | Agonist | 99.52% | Unkown |
| HY-101087 | Benzenesulphonamide | Inhibitor | 99.75% | Unkown |
| HY-118010A | (+)-Norfenfluramine hydrochloride | Agonist | 99.77% | Unkown |
| HY-15466 | Izorlisib | 99.01% | Unkown | |
| HY-34740 | Ethylmalonic acid | Inhibitor | 98.0% | Unkown |
| HY-101955A | (2R,6R)-Hydroxynorketamine hydrochloride | 99.91% | Unkown | |
| HY-114400 | TRPV4 agonist-1 free base | Agonist | 99.69% | Unkown |
| HY-130118 | MRGPRX1 agonist 1 | Agonist | 99.95% | Unkown |
| HY-108593 | BMS-191011 | Activator | 99.56% | Unkown |
| HY-131900 | Protein kinase inhibitor H-7 | Inhibitor | 99.96% | Unkown |
| HY-158779 | Sulfane sulfur probe 4 | 97.3% | Unkown | |
| HY-D1024A | Coelenterazine h hydrochloride | 99.65% | Unkown | |
| HY-N0084 | Betulinaldehyde | Inhibitor | 98.72% | Unkown |
| HY-N0642 | α-L-Rhamnose monohydrate | Activator | 98.0% | Unkown |
| HY-N4104 | Agaric acid | 99.45% | Unkown | |
| HY-N7063 | Nerol | 98.97% | Unkown | |
| HY-P1075 | CALP3 | Inhibitor | 99.18% | Unkown |
| HY-P1341 | OXA(17-33) | 97.48% | Unkown | |
| HY-W041308 | DCOIT | Agonist | 99.87% | Unkown |
| HY-W110910 | Eriochrome black T, Indicator | / | Unkown | |
| HY-12498 | GV-58 | Agonist | 99.22% | Unkown |
| HY-147301 | Resomelagon | Agonist | 98.79% | Unkown |
| HY-108608 | o-3M3FBS | 99.79% | Unkown | |
| HY-116291 | 4α-Phorbol 12,13-didecanoate | 99.30% | Unkown | |
| HY-124873 | SERCA2a activator 1 | Activator | 99.71% | Unkown |
| HY-128747A | α-D-Glucose-1-phosphate disodium hydrate | 98.0% | Unkown | |
| HY-129126 | NC9 | Inhibitor | 99.98% | Unkown |
| HY-12927 | SX-517 | Antagonist | 99.90% | Unkown |
| HY-34740S | Ethylmalonic acid-d3 | Inhibitor | 98.0% | Unkown |
| HY-N0215S11 | L-Phenylalanine-13C9,15N | Antagonist | 99.42% | Unkown |
| HY-N0215S5 | L-Phenylalanine-15N | Antagonist | 98.38% | Unkown |
| HY-Y1422I | Lipase,Pseudomonas fluorescens (Immobilized) | / | Unkown | |
| HY-101396 | ICA-069673 | Activator | 99.20% | Unkown |
| HY-100783 | (-)-Bicuculline methobromide | Antagonist | 99.94% | Unkown |
| HY-104058 | BAPTA Green 1AM | 92.0% | Unkown | |
| HY-110018 | N-Arachidonyldopamine | 98.36% | Unkown | |
| HY-P3089A | Dendrotoxin K TFA | Inhibitor | 99.84% | Unkown |
| HY-P3965 | 16-38-Thymosin β4 (cattle) | Activator | 98.05% | Unkown |
| HY-W010710 | IPrAuCl | Inhibitor | 98.2% | Unkown |
| HY-12759A | CARM1-IN-1 hydrochloride | Inhibitor | 95.17% | Unkown |
| HY-12949A | ML204 hydrochloride | Inhibitor | 99.74% | Unkown |
| HY-103442 | CGP52411 | Inhibitor | 99.82% | Unkown |
| HY-108464A | Phenamil methanesulfonate | Inhibitor | 98.1% | Unkown |
| HY-117073 | ITH12575 | Inhibitor | 98.84% | Unkown |
| HY-135556 | Norfluoxetine | 98.71% | Unkown | |
| HY-136661 | (-)-N6-Phenylisopropyl adenosine | Agonist | 99.45% | Unkown |
| HY-175416 | Yoda2 | Agonist | 99.57% | Unkown |
| HY-D0202 | Arsenazo III | 95.0% | Unkown | |
| HY-DY1028 | Fluo-4 AM (solution) | / | Unkown | |
| HY-E70200 | Recombinant Kex2 protease | / | Unkown | |
| HY-N2060 | Evocarpine | 99.88% | Unkown | |
| HY-P1077A | CALP1 TFA | 98.15% | Unkown | |
| HY-P1821A | Myelin basic protein (4-14) TFA | 99.41% | Unkown | |
| HY-W012399 | 2,5-Di-tert-butylhydroquinone | 99.73% | Unkown | |
| HY-W074975 | CL 5343 | Inhibitor | 99.91% | Unkown |
| HY-W181102 | NFAT Inhibitor-2 | Inhibitor | 98.42% | Unkown |
| HY-137175 | TMBIM6 antagonist-1 | Antagonist | 98.92% | Unkown |
| HY-137458 | Vevorisertib | Inhibitor | 98.03% | Unkown |
| HY-137849 | RK-582 | Inhibitor | 98.05% | Unkown |
| HY-100656 | Desmethyl cariprazine | Antagonist | 98.08% | Unkown |
| HY-103317 | NAADP | 95.8% | Unkown | |
| HY-108496S | Sphingosine-1-phosphate-d7 | Agonist | 99.9% | Unkown |
| HY-108607 | PACOCF3 | Inhibitor | 98.0% | Unkown |
| HY-113037CS | Farnesyl pyrophosphate-d2 triammonium | Agonist | 95.78% | Unkown |
| HY-135746 | OR-1896 | 99.04% | Unkown | |
| HY-B1671 | (+)-Kavain | 99.98% | Unkown | |
| HY-D0110A | Fura-2 pentapotassium | 97.0% | Unkown | |
| HY-N0215S3 | L-Phenylalanine-d2 | Antagonist | 99.00% | Unkown |
| HY-N0215S7 | L-Phenylalanine-3-13C | Antagonist | 99.56% | Unkown |
| HY-N1584C | Halofuginone lactate | 98.32% | Yes | |
| HY-N6688 | Verruculogen | Inhibitor | 98.08% | Unkown |
| HY-N7575 | Lacto-N-fucopentaose II | 98.0% | Unkown | |
| HY-P1831 | Proadrenomedullin (1-20), human | 99.53% | Unkown | |
| HY-P5189A | His-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH2 TFA | 99.94% | Unkown | |
| HY-W749867 | Ca(II)-EDTA disodium dihydrate | 99.9% | Unkown | |
| HY-N0215S2 | L-Phenylalanine-13C | Antagonist | 99.66% | Unkown |
| HY-N7491A | Ent-(+)-Verticilide | Inhibitor | 99.91% | Unkown |
| HY-18256 | Ombrabulin hydrochloride | Inhibitor | 99.57% | Yes |
| HY-110023 | Zimelidine dihydrochloride | Inhibitor | 98.08% | Unkown |
| HY-110153 | NS19504 | Activator | 99.93% | Unkown |
| HY-125703 | Ferutinin | 99.23% | Unkown | |
| HY-128678 | ORM-10103 | Inhibitor | 99.43% | Unkown |
| HY-136909 | SR33805 | Antagonist | 99.78% | Unkown |
| HY-145127 | ETZ | 99.84% | Unkown | |
| HY-146268 | CaMKIIα-IN-1 | Inhibitor | 98.53% | Unkown |
| HY-161104 | Kv2.1-IN-1 | Inhibitor | 98.64% | Unkown |
| HY-P0271A | Syntide 2 TFA | 99.70% | Unkown | |
| HY-P1076A | CALP2 TFA | Antagonist | 98.31% | Unkown |
| HY-P1080 | ω-Agatoxin IVA | Inhibitor | 98.71% | Unkown |
| HY-P1247 | Calcineurin autoinhibitory peptide | Inhibitor | 99.99% | Unkown |
| HY-P3187 | exo-β-1,4-Xylosidase, Cellulosimicrobium cellulans sp. 21 | / | Unkown | |
| HY-W017387S | Sodium α-ketoisocaproate-d3 | 98.48% | Unkown | |
| HY-19721 | ABT-639 | Inhibitor | 98.67% | Unkown |
| HY-105118A | Zaldaride maleate | Antagonist | 99.7% | Unkown |
| HY-103544 | [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P | 99.75% | Unkown | |
| HY-108592 | UCL 2077 | Inhibitor | 98.91% | Unkown |
| HY-110292 | A-425619 | 99.96% | Unkown | |
| HY-111527 | PPZ2 | 99.92% | Unkown | |
| HY-121584 | Lycoperodine-1 | Agonist | 99.82% | Unkown |
| HY-124594 | CA inhibitor 1 | Inhibitor | 99.77% | Unkown |
| HY-136182 | YM-244769 dihydrochloride | Inhibitor | 98.57% | Unkown |
| HY-136182A | YM-244769 | Inhibitor | 99.22% | Unkown |
| HY-136980 | Aspartylglutamate | 99.79% | Unkown | |
| HY-155480 | PSB-22034 | Agonist | 99.61% | Unkown |
| HY-15809 | (Rac)-Ibrutinib alkyne | Inhibitor | 99.35% | Unkown |
| HY-B0265A | (R)-Nimodipine | Antagonist | 99.87% | Unkown |
| HY-B0782S | Acetazolamide-d3 | Inhibitor | 99.9% | Unkown |
| HY-E70234A | Sortase A, S. aureus (non-Ca2+-dependent) | 96.90% | Unkown | |
| HY-N1940 | β-Anhydroicaritin | Inhibitor | 99.69% | Unkown |
| HY-N2157 | Pteryxin | Inhibitor | 99.55% | Unkown |
| HY-NP164B | Concanavalin A-AF488 | / | Unkown | |
| HY-P2757 | Phosphorylase kinase | / | Unkown | |
| HY-P3617 | Glucagon (22-29) | Agonist | 98.12% | Unkown |
| HY-41076 | Ca2+ channel agonist 1 | 98.87% | Unkown | |
| HY-D0077 | 2',7'-Difluorofluorescein | 99.52% | Unkown | |
| HY-N0742 | Absinthin | Agonist | 98.0% | Unkown |
| HY-165607S | MCB-22-174 | 99.78% | Unkown | |
| HY-103277A | BIM 23042 TFA | Antagonist | 99.75% | Unkown |
| HY-103317A | NAADP tetrasodium | 99.1% | Unkown | |
| HY-118824A | N-Feruloylserotonin | Inhibitor | 99.93% | Unkown |
| HY-12550 | GW542573X | Activator | 99.79% | Unkown |
| HY-126583 | Nemadipine-A | Inhibitor | 98.87% | Unkown |
| HY-130368 | W-7 | 99.35% | Unkown | |
| HY-136190 | TRPC6-PAM-C20 | Agonist | 99.78% | Unkown |
| HY-149483 | CVN417 | Antagonist | 99.93% | Unkown |
| HY-A0236A | Aprindine hydrochloride | Inhibitor | 98.96% | Unkown |
| HY-D0121A | INDO 1 pentapotassium | 96.43% | Unkown | |
| HY-N7117 | 1,4-Cineole | Activator | 95.0% | Unkown |
| HY-P0256A | Apamin TFA | Inhibitor | 97.49% | Unkown |
| HY-P3037A | Imperatoxin A TFA | Activator | 98.25% | Unkown |
| HY-W013857 | Lavendustin C | Inhibitor | 98.17% | Unkown |
| HY-W344044 | Levomepromazine maleate | 99.92% | Unkown | |
| HY-W854385A | Sialyl Lewis A sodium | / | Unkown | |
| HY-100928 | YS 035 hydrochloride | Antagonist | 99.15% | Unkown |
| HY-107859S | Tris(2-chloroethyl)phosphate-d12 | 99.15% | Unkown | |
| HY-137172 | ETH 157 | 99.52% | Unkown | |
| HY-141581 | Lyso-PAF C-18 | Modulator | 99.74% | Unkown |
| HY-103320B | (1R,2R)-Calhex 231 hydrochloride | Control | 98.45% | Unkown |
| HY-10388A | TTA-Q6(isomer) | 99.91% | Unkown | |
| HY-107855S | DL-Mevalonolactone-d7 | 99.27% | Unkown | |
| HY-110140 | (E)-KN-93 phosphate | Inhibitor | 99.85% | Unkown |
| HY-119282 | AZD6538 | Inhibitor | / | Unkown |
| HY-121825 | U-44069 | Control | 98.0% | Unkown |
| HY-129496 | NP-313 | Inhibitor | 99.31% | Unkown |
| HY-131012 | GoSlo-SR-5-69 | Activator | 99.26% | Unkown |
| HY-131041 | Ned-K | 99.35% | Unkown | |
| HY-13338 | Mabuterol | Agonist | 99.96% | Unkown |
| HY-151917 | Enpp/Carbonic anhydrase-IN-2 | Inhibitor | 98.48% | Unkown |
| HY-170360 | UCB9386 | Inhibitor | 99.89% | Unkown |
| HY-174140 | VU0514009 | Antagonist | 99.53% | Unkown |
| HY-175593 | M6766 | 99.43% | Unkown | |
| HY-176550 | ASIC1a antagonist-1 | Antagonist | 98.00% | Unkown |
| HY-176710 | PAD-PF2 | 99.94% | Unkown | |
| HY-18071A | BI-9627 hydrochloride | Inhibitor | 98.01% | Unkown |
| HY-B0246S4 | Carbamazepine-d4 | 99.72% | Unkown | |
| HY-N9404 | 6-Benzoylheteratisine | Inhibitor | 99.58% | Unkown |
| HY-P1079 | ω-Agatoxin TK | Inhibitor | ≥99.0% | Unkown |
| HY-P11205A | Cys-PKHB1 TFA | Activator | 99.43% | Unkown |
| HY-P1250 | RFRP-3(human) | Agonist | 99.43% | Unkown |
| HY-P1387 | β-Amyloid (1-40) (rat) | Inducer | / | Unkown |
| HY-P1805 | Calmodulin Binding Peptide 1 | Ligand | 98.68% | Unkown |
| HY-W134005 | Mg(Ⅱ)-EDTA disodium tetrahydrate | 99.16% | Unkown | |
| HY-W641445 | ELP-004 | Inhibitor | 99.89% | Unkown |
| HY-100656AS | Desmethyl cariprazine-d8 | 99.93% | Unkown | |
| HY-126789A | DM-Nitrophen tertasodium | 90.0% | Unkown | |
| HY-130309 | (±)8(9)-EpETE | 99.9% | Unkown | |
| HY-W010252 | N-Benzylethylenediamine | 99.79% | Unkown | |
| HY-W1113135 | Carboxymethyl-β-cyclodextrin sodium salt | 99.6% | Unkown | |
| HY-14656S | Diltiazem-d3 hydrochloride | Antagonist | 98.70% | Unkown |
| HY-100402 | CFMTI | Antagonist | 98.0% | Unkown |
| HY-101390 | (+)-Niguldipine hydrochloride | Ligand | 98.06% | Unkown |
| HY-103078 | I-XW-053 | Inhibitor | 99.71% | Unkown |
| HY-103472 | FPR-A14 | Agonist | 98.58% | Unkown |
| HY-11000A | CaMKP inhibitor sodium | Inhibitor | 98.06% | Unkown |
| HY-111014 | VK-II-36 | Activator | 99.62% | Unkown |
| HY-115767 | (±)-1,2-Diolein | Activator | 97.0% | Unkown |
| HY-145384 | ROC-0929 | Inhibitor | 99.62% | Unkown |
| HY-147005 | piCRAC-1 | Inhibitor | 99.36% | Unkown |
| HY-147301A | Resomelagon acetate | Agonist | 99.15% | Unkown |
| HY-155516 | KV1.3-IN-1 | Inhibitor | 98.34% | Unkown |
| HY-15705 | GPR35 agonist 2 | 98.61% | Unkown | |
| HY-165473 | Hexadecylphosphoserine | Activator | / | Unkown |
| HY-165473A | Hexadecylphosphoserine TFA | Activator | 98.0% | Unkown |
| HY-173537 | D-myo-Inositol-1,2,4,5-tetraphosphate tetrasodium salt | 98.0% | Unkown | |
| HY-176745 | SW016789 | Inducer | 99.85% | Unkown |
| HY-76779 | 4-(Chloromethyl)-7-hydroxycoumarin | 98.01% | Unkown | |
| HY-B0493S1 | Niflumic acid-13C6 | Inhibitor | 99.8% | Unkown |
| HY-B1221S1 | Flufenamic acid-13C6 | / | Unkown | |
| HY-D1631 | Calcium Green-5N AM | / | Unkown | |
| HY-DY1095 | Fluo-3AM (solution) | / | Unkown | |
| HY-N0126R | Xanthone (Standard) | Inhibitor | 99.99% | Unkown |
| HY-N0215S14 | L-Phenylalanine-15N,d8 | Antagonist | 99.90% | Unkown |
| HY-N4237 | Saikogenin D | 99.99% | Unkown | |
| HY-N5130 | Effusol | 99.83% | Unkown | |
| HY-P1077 | CALP1 | 98.44% | Unkown | |
| HY-P11292 | Caloxin 1b3 | Inhibitor | 99.81% | Unkown |
| HY-P1397A | RVD-Hpα TFA | Agonist | 98.92% | Unkown |
| HY-P1640 | (Trp63,Trp64)-C3a(63-77) | Agonist | 99.23% | Unkown |
| HY-P3811A | Autocamtide-3 acetate | 99.95% | Unkown | |
| HY-P5142A | ω-Hexatoxin-Hv1a TFA | Inhibitor | 97.49% | Unkown |
| HY-P6292 | KS-133 | 98.75% | Unkown | |
| HY-RS01776 | CA9 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS11007 | PPP2CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W010221 | Phenyltrimethylammonium hydroxide | 98.0% | Unkown | |
| HY-W748509 | Pipernonaline | 99.30% | Unkown | |
| HY-101329S | Anthracene-9-carboxylic acid-d9 | 98.01% | Unkown | |
| HY-126789 | DM-Nitrophen | 98.40% | Unkown | |
| HY-154924 | Thio-NADP | 96.57% | Unkown | |
| HY-15515R | SEA0400 (Standard) | Inhibitor | 98.11% | Unkown |
| HY-N16129 | Diplacone | 98.38% | Unkown | |
| HY-N4308 | Hexamethylquercetagetin | Inhibitor | 98.0% | Unkown |
| HY-RS10523 | PIK3CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W587805 | Perfluorohexane sulfonamide | Inhibitor | / | Unkown |
| HY-Y0258S | Benzocaine-d4 | 99.34% | Unkown | |
| HY-B0124S | Zonisamide-d4 | Inhibitor | 99.11% | Unkown |
| HY-101902 | Quin-2AM | / | Unkown | |
| HY-100718 | SCH00013 | Activator | / | Unkown |
| HY-101015 | (2E)-OBAA | / | Unkown | |
| HY-101428 | NS-638 | Inhibitor | 99.84% | Unkown |
| HY-101693A | Senazodan hydrochloride | Inhibitor | 99.84% | Unkown |
| HY-103308 | TRAM-39 | Inhibitor | 99.66% | Unkown |
| HY-10388 | TTA-Q6 | Antagonist | 99.97% | Unkown |
| HY-104056 | Fura Red | / | Unkown | |
| HY-106784A | (E)-Ajoene | 95% | Unkown | |
| HY-107659 | YM-244769 hydrochloride | Inhibitor | 98.09% | Unkown |
| HY-107678 | SEN12333 | Agonist | 98.45% | Unkown |
| HY-108515 | (R)-Igmesine hydrochloride | 99.0% | Unkown | |
| HY-112741 | SB-209247 | Antagonist | 99.33% | Unkown |
| HY-113970A | Nebracetam hydrochloride | 99.0% | Unkown | |
| HY-115745 | Calmodulin antagonist-1 | Antagonist | 98.0% | Unkown |
| HY-120514 | JNc-440 | 98.04% | Unkown | |
| HY-120528 | GB-110 | Agonist | / | Unkown |
| HY-121604 | (Rac)-MEM 1003 | Inhibitor | 99.64% | Unkown |
| HY-124176 | L-6355 | / | Unkown | |
| HY-129146S | Doxapram-d5 hydrochloride | Inhibitor | 99.0% | Unkown |
| HY-131040 | NLRP3-IN-NBC6 | Inhibitor | 99.40% | Unkown |
| HY-131948 | 3-Chlorodiphenylamine | Activator | 98.74% | Unkown |
| HY-132190 | Hexanolamino PAF C-16 | Antagonist | 99.9% | Unkown |
| HY-132239 | 5-Bromo-6-chloro-3-indolyl β-D-Galactopyranoside contains ca. 10% Ethyl Acetate | 99.58% | Unkown | |
| HY-135110 | Rp-8-Br-cGMPS sodium | 99.9% | Unkown | |
| HY-13617 | Edatrexate | / | Unkown | |
| HY-136395 | Cartap | Inducer | / | Unkown |
| HY-137459 | Vocacapsaicin | Agonist | / | Unkown |
| HY-141712 | ZA18 | Inhibitor | 99.72% | Unkown |
| HY-147377 | N-Salicyloyltryptamine | 96.37% | Unkown | |
| HY-148135 | hCAI/II-IN-6 | Inhibitor | 98.0% | Unkown |
| HY-149301 | hCAIX-IN-18 | Inhibitor | 98.52% | Unkown |
| HY-151916 | Enpp/Carbonic anhydrase-IN-1 | 99.57% | Unkown | |
| HY-15293 | JTV-519 | Inhibitor | 98.0% | Unkown |
| HY-15293A | JTV-519 free base | Inhibitor | / | Unkown |
| HY-15671A | GKA50 quarterhydrate | Activator | ≥98.0% | Unkown |
| HY-16489A | Terodiline hydrochloride | Antagonist | 99.78% | Unkown |
| HY-173191 | SK-124 | Inhibitor | 95.0% | Unkown |
| HY-19857 | Sulcardine sulfate | / | Unkown | |
| HY-B0561S4 | Spironolactone-d6-1 | 99.26% | Unkown | |
| HY-B1837A | β-Cyfluthrin | Inhibitor | 99.94% | Unkown |
| HY-B1873 | Methoxychlor | Inducer | 99.41% | Unkown |
| HY-DY1101 | Fura-2 AM (solution) | / | Unkown | |
| HY-N0252A | Catharanthine Tartrate | Inhibitor | 98.88% | Unkown |
| HY-N0252B | Catharanthine Sulfate | Inhibitor | / | Unkown |
| HY-N10116A | Calamenene | / | Unkown | |
| HY-N10772 | Albanin A | Inhibitor | 97.67% | Unkown |
| HY-N1989 | Bacoside A | / | Unkown | |
| HY-N4267 | Yangambin | 98.27% | Unkown | |
| HY-N7063R | Nerol (Standard) | 98.71% | Unkown | |
| HY-N7875 | Celangulin | 95.93% | Unkown | |
| HY-NP164L | Concanavalin A-AF647 | / | Unkown | |
| HY-P0271 | Syntide 2 | / | Unkown | |
| HY-P1479A | Calmodulin-Dependent Protein Kinase II(290-309) acetate | 98.45% | Unkown | |
| HY-P3037 | Imperatoxin A | Activator | / | Unkown |
| HY-P3965A | 16-38-Thymosin β4 (cattle) TFA | Activator | 98.14% | Unkown |
| HY-P5154A | Tamapin TFA | Antagonist | 98.79% | Unkown |
| HY-P5914 | Wasabi Receptor Toxin | Activator | / | Unkown |
| HY-P5914A | Wasabi Receptor Toxin TFA | Activator | 99.49% | Unkown |
| HY-P5988 | N-myristoyl-RKRTLRRL | Inhibitor | 99.37% | Unkown |
| HY-P6013A | wt hMLN TFA | Inhibitor | 95.0% | Unkown |
| HY-Q40876 | BBT | Modulator | 99.71% | Unkown |
| HY-W250149 | Chlorophosphonazo III | / | Unkown | |
| HY-W854385 | Sialyl Lewis A | / | Unkown | |
| HY-Y0258R | Benzocaine (Standard) | 99.99% | Unkown | |
| HY-Y0258S1 | Benzocaine-(ethyl-d5) | 99.0% | Unkown | |
| HY-Y1422E | Lipase,Aspergillusniger (Immobilized) | / | Unkown | |
| HY-101693 | Senazodan | Inhibitor | / | Unkown |
| HY-12962 | NMDA-IN-1 | Antagonist | 98.98% | Unkown |
| HY-132191 | Pradimicin A | Inhibitor | / | Unkown |
| HY-134261A | 8-Br-ADPR disodium | Inhibitor | / | Unkown |
| HY-150135B | D-myo-Inositol 1,4,5-trisphosphate tripotassium | Activator | 98.00% | Unkown |
| HY-70037AS | Cinacalcet-d3 hydrochloride | Agonist | 97.63% | Unkown |
| HY-B1193S | Terfenadine-d3 | 99.06% | Unkown | |
| HY-B2217D | Calcium hydroxide, ACS, 95% | Inhibitor | / | Unkown |
| HY-I0096R | Indole-2-carboxylic acid (Standard) | Inhibitor | 99.78% | Unkown |
| HY-N0215S | L-Phenylalanine-d7 | Antagonist | 99.90% | Unkown |
| HY-N2359 | Chelerythrine | / | Unkown | |
| HY-RS21174 | Ppp2ca Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011235S | Norfluoxetine-d5 hydrochloride | 99.30% | Unkown | |
| HY-W400427 | α-D-Glucose-1-phosphate | ≥97.0% | Unkown | |
| HY-W654243 | Isovalerylcarnitine-d9-1 chloride | Activator | 99.55% | Unkown |
| HY-111207 | CA224 | 99.94% | Unkown | |
| HY-135317B | Emavusertib hydrochloride | / | Unkown | |
| HY-114400A | TRPV4 agonist-1 | Agonist | / | Unkown |
| HY-169964 | TSPO/Carbonic Anhydrase Modulator 1 | Modulator | / | Unkown |
| HY-B0551S | Doxapram-d8 | Inhibitor | 99.54% | Unkown |
| HY-B0782S1 | Acetazolamide-13C2,d3 | / | Unkown | |
| HY-100424 | PI3K-IN-63 | Inhibitor | / | Unkown |
| HY-102085 | 11-Deoxyglycyrrhetinic acid sodium | Activator | / | Unkown |
| HY-103309A | ML218 hydrochloride | Inhibitor | / | Unkown |
| HY-125836 | CCR4 antagonist 2 | Antagonist | / | Unkown |
| HY-184055 | NMDA receptor antagonist-12 | Antagonist | / | Unkown |
| HY-19805A | STO-609 acetate | Inhibitor | / | Unkown |
| HY-N1584B | Halofuginone hydrochloride | / | Unkown | |
| HY-135556AS | Norfluoxetine-d5 | / | Unkown | |
| HY-B0632S | Diltiazem-d6 | Antagonist | / | Unkown |
| HY-N1369S | Menthol-d4 | / | Unkown | |
| HY-P2471 | Neurogranin (48-76), mouse | Inhibitor | / | Unkown |
| HY-10050 | CJ-17493 | Antagonist | / | Unkown |
| HY-100783A | (+)-Bicuculline methochloride | Antagonist | / | Unkown |
| HY-100783B | Bicuculline methobromide | Antagonist | / | Unkown |
| HY-100843 | L-AP6 | / | Unkown | |
| HY-100981 | MR-16728 hydrochloride | / | Unkown | |
| HY-10167 | Tecalcet | Modulator | / | Unkown |
| HY-101685A | Iganidipine dihydrochloride | Antagonist | / | Unkown |
| HY-103078A | I-XW-053 sodium | Inhibitor | / | Unkown |
| HY-103277 | BIM 23042 | Antagonist | / | Unkown |
| HY-103309S | ML218-d9 | Inhibitor | / | Unkown |
| HY-103313 | SR33805 oxalate | Antagonist | / | Unkown |
| HY-103320 | Calhex 231 | Antagonist | / | Unkown |
| HY-103545 | GIP (1-39) | Agonist | / | Unkown |
| HY-103660S | 18:0 LYSO-PE-d35 | / | Unkown | |
| HY-105118 | Zaldaride | Inhibitor | / | Unkown |
| HY-105402 | T 162559 | Inhibitor | / | Unkown |
| HY-105415 | U 92032 | Inhibitor | / | Unkown |
| HY-106428 | Icrocaptide | Inhibitor | / | Unkown |
| HY-106525 | Aclatonium napadisylate | Agonist | / | Unkown |
| HY-106761 | Oxodipine | Antagonist | / | Unkown |
| HY-106818A | Monatepil maleate | / | Unkown | |
| HY-107111A | GSK1034702 hydrochloride | Agonist | / | Unkown |
| HY-107855S1 | DL-Mevalonolactone-d3 | / | Unkown | |
| HY-108163A | SB-237376 | / | Unkown | |
| HY-108659 | NF340 | / | Unkown | |
| HY-109056A | Elsulfavirine sodium | Inhibitor | / | Unkown |
| HY-109106B | (Rac)-Upacicalcet | 95.0% | Unkown | |
| HY-110023R | Zimelidine dihydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-111198 | YM-355179 fumarate | / | Unkown | |
| HY-111214 | K-14585 | / | Unkown | |
| HY-111964S1 | Lenacapavir-d5 | Inhibitor | / | Unkown |
| HY-112393 | TX-1918 | Inhibitor | / | Unkown |
| HY-113658 | ts-SA | / | Unkown | |
| HY-113920 | Azumolene sodium | Inhibitor | / | Unkown |
| HY-114554 | KS 619-1 | Inhibitor | / | Unkown |
| HY-114691 | R 59494 | Inhibitor | / | Unkown |
| HY-114743 | GS 283 | Antagonist | / | Unkown |
| HY-114826 | Prostaglandin E2-1-glyceryl ester | Activator | / | Unkown |
| HY-114990 | EMD 57439 | Inhibitor | / | Unkown |
| HY-115493 | TIQ-15 | Antagonist | / | Unkown |
| HY-115998 | Carbonic anhydrase inhibitor 11 | Inhibitor | / | Unkown |
| HY-115999 | Carbonic anhydrase inhibitor 12 | Inhibitor | / | Unkown |
| HY-116153 | HUHS2002 | / | Unkown | |
| HY-116312 | 8-pCPT-2′-O-Me-cAMP | Activator | / | Unkown |
| HY-116330 | Hyperforin | / | Unkown | |
| HY-116429A | 7(S)-Maresin 1 | / | Unkown | |
| HY-116429S | Maresin 1-d5 | Inhibitor | / | Unkown |
| HY-116500A | AH-1058 | Antagonist | / | Unkown |
| HY-116540 | L 858051 | Activator | / | Unkown |
| HY-116540A | L 858051 dihydrochloride | Activator | / | Unkown |
| HY-117099 | TMB-8 | Antagonist | 98.0% | Unkown |
| HY-117578 | KB 5666 | / | Unkown | |
| HY-118817 | Evariquinone | Inhibitor | / | Unkown |
| HY-118835 | Zimelidine | Inhibitor | / | Unkown |
| HY-119386 | SAS-0132 | / | Unkown | |
| HY-119850A | Aladorian sodium | Modulator | / | Unkown |
| HY-119919 | Clofenamide | Inhibitor | / | Unkown |
| HY-120321 | DSR-71167 | / | Unkown | |
| HY-120699 | RO5488608 | Modulator | / | Unkown |
| HY-120764 | PF-46396 | Inhibitor | / | Unkown |
| HY-120820 | LY320954 | Antagonist | / | Unkown |
| HY-120985 | Araguspongin B | Antagonist | / | Unkown |
| HY-121235S1 | Clonixin-13C,d3 | Inhibitor | / | Unkown |
| HY-121299 | m-Chlorophenylbiguanide | ≥90.0% | Unkown | |
| HY-121516 | CM-TPMF | 99.91% | Unkown | |
| HY-12153 | JNJ-1930942 | Modulator | / | Unkown |
| HY-12155 | JNJ-26990990 | Inhibitor | / | Unkown |
| HY-121690 | Semotiadil | Antagonist | / | Unkown |
| HY-121966 | Riparin | 98.00% | Unkown | |
| HY-12292G | IM-12 (GMP) | / | Unkown | |
| HY-123009 | KCN1 | / | Unkown | |
| HY-123659 | KR-33028 | Inhibitor | / | Unkown |
| HY-124985 | VU6010608 | Modulator | / | Unkown |
| HY-12542S | Dantrolene-13C3 | Inhibitor | 99.0% | Unkown |
| HY-125641A | AL-34662 formate | Agonist | / | Unkown |
| HY-126821 | Fluo-3 | / | Unkown | |
| HY-126821A | Fluo-3 pentaammonium | / | Unkown | |
| HY-128547 | Cetiedil citrate | / | Unkown | |
| HY-129088 | HUP30 | 99.68% | Unkown | |
| HY-129547 | Fluo-3 pentapotassium | / | Unkown | |
| HY-12962A | NMDA-IN-1 dihydrochloride | Antagonist | / | Unkown |
| HY-129781 | L-650719 | Inhibitor | / | Unkown |
| HY-130070 | QO-40 | Activator | 98.77% | Unkown |
| HY-131001 | DPNB-ABT594 | Agonist | / | Unkown |
| HY-131691 | NMDAR blocker 1 | / | Unkown | |
| HY-131942 | sFTX-3.3 | Antagonist | / | Unkown |
| HY-132227 | Dichlorobenzamil hydrochloride | Inhibitor | / | Unkown |
| HY-133596 | 12,14-Dichlorodehydroabietic acid | / | Unkown | |
| HY-134261 | 8-Br-ADPR | Inhibitor | / | Unkown |
| HY-135433 | MAPTAM | / | Unkown | |
| HY-135478 | LY393615 | Inhibitor | / | Unkown |
| HY-135601 | Cinacalcet metabolite M4 | / | Unkown | |
| HY-135746S | OR-1896-d3 | / | Unkown | |
| HY-136189 | UK-59811 hydrochloride | Inhibitor | / | Unkown |
| HY-136283 | DMNPE-4 AM-caged-calcium | Ligand | / | Unkown |
| HY-136894 | Rhod-5N | / | Unkown | |
| HY-137203 | (+)-Niguldipine | / | Unkown | |
| HY-13764A | dl-Tetrandrine | Inhibitor | / | Unkown |
| HY-137952 | NS8593 | Inhibitor | / | Unkown |
| HY-138302 | PF-06862309 | / | Unkown | |
| HY-138951 | AY77 | Agonist | / | Unkown |
| HY-138990 | GK563 | Inhibitor | / | Unkown |
| HY-139041 | Palmitoylcholine chloride | Inhibitor | 99.52% | Unkown |
| HY-139145 | Etbicyphat | Antagonist | 98.0% | Unkown |
| HY-139145S | Etbicyphat-13C3 | / | Unkown | |
| HY-141564 | RyR1-IN-1 | Inhibitor | / | Unkown |
| HY-141581S | Lyso-PAF C-18-d4 | Modulator | / | Unkown |
| HY-141713 | ZA10 | Inhibitor | / | Unkown |
| HY-142050 | (R)-IDHP | / | Unkown | |
| HY-142087 | Beauverolide Ja | Inhibitor | / | Unkown |
| HY-142117 | Adenophostin A | Activator | / | Unkown |
| HY-143460 | CAXII-IN-1 | Inhibitor | / | Unkown |
| HY-144222 | NSC 828467 | Inhibitor | / | Unkown |
| HY-144807 | Carbonic anhydrase inhibitor 9 | Inhibitor | / | Unkown |
| HY-145196 | RTICBM-189 | Modulator | 99.73% | Unkown |
| HY-145385 | Coelenteramide | / | Unkown | |
| HY-145900 | S100A2-p53-IN-1 | Inhibitor | / | Unkown |
| HY-146010 | Carbonic anhydrase inhibitor 13 | Inhibitor | / | Unkown |
| HY-146232 | F 13714 | Agonist | / | Unkown |
| HY-146252 | hCAXII-IN-4 | Inhibitor | / | Unkown |
| HY-146259 | hCAIX/XII-IN-4 | Inhibitor | / | Unkown |
| HY-146461 | Anticancer agent 58 | / | Unkown | |
| HY-146462 | Anticancer agent 59 | / | Unkown | |
| HY-14656S1 | Diltiazem-(acetoxy-d3) hydrochloride | Antagonist | / | Unkown |
| HY-14656S4 | Diltiazem-d4-1 hydrochloride | Antagonist | / | Unkown |
| HY-146819 | CAIX/CAXII-IN-1 | / | Unkown | |
| HY-146982 | hCAII-IN-1 | Inhibitor | / | Unkown |
| HY-146983 | hCAIX-IN-3 | Inhibitor | / | Unkown |
| HY-147186 | 5,5'-Difluoro BAPTA | / | Unkown | |
| HY-149011 | CA IX-IN-1 | Inhibitor | / | Unkown |
| HY-149342 | α-Glucosidase-IN-29 | Inhibitor | / | Unkown |
| HY-150039 | CCG-271423 | Inhibitor | / | Unkown |
| HY-15016 | (E/Z)-OT-R antagonist 1 | Antagonist | / | Unkown |
| HY-15018A | SSR126768A free base | Antagonist | / | Unkown |
| HY-150536 | EP39 | Inhibitor | / | Unkown |
| HY-150570 | Carbonic anhydrase inhibitor 14 | Inhibitor | / | Unkown |
| HY-150695 | hCAIX/XII-IN-5 | / | Unkown | |
| HY-150782 | UNC-CA359 | Inhibitor | / | Unkown |
| HY-151451 | Cav 3.2 inhibitor 2 | Inhibitor | / | Unkown |
| HY-151452 | Cav 3.2 inhibitor 3 | Inhibitor | / | Unkown |
| HY-151472 | hCAIX/XII-IN-6 | Inhibitor | / | Unkown |
| HY-151493 | CAII-IN-1 | Inhibitor | / | Unkown |
| HY-151494 | CAII-IN-2 | Inhibitor | / | Unkown |
| HY-151495 | CAII-IN-3 | Inhibitor | / | Unkown |
| HY-151547 | MRS4719 | Antagonist | / | Unkown |
| HY-151547S | MRS4719-d3 | / | Unkown | |
| HY-151578 | DPP IV/hCA II-IN-1 | Inhibitor | / | Unkown |
| HY-151633 | hCAIX-IN-14 | Inhibitor | / | Unkown |
| HY-152140 | hCAII-IN-8 | Inhibitor | 99.41% | Unkown |
| HY-155694 | hCA/VEGFR-2-IN-1 | Inhibitor | / | Unkown |
| HY-156013 | CA inhibitor 2 | Inhibitor | / | Unkown |
| HY-156082 | RyRs activator 3 | Inhibitor | / | Unkown |
| HY-156104 | CaMKIIα-PHOTAC | Degrader | / | Unkown |
| HY-156181 | hCAIX/XII-IN-8 | Inhibitor | / | Unkown |
| HY-157139 | ALP/Carbonic anhydrase-IN-1 | Inhibitor | 99.90% | Unkown |
| HY-158328A | CA IX/VEGFR-2-IN-2 | / | Unkown | |
| HY-159122 | CA IX-IN-2 | / | Unkown | |
| HY-159861 | Ionizable Lipid 4 | / | Unkown | |
| HY-159870 | E12CA1A3 | / | Unkown | |
| HY-160099S | 20-5,14-HEDE-d2 | / | Unkown | |
| HY-160099S1 | 20-5,14-HEDE-d2-1 | / | Unkown | |
| HY-160099S2 | 20-5,14-HEDE-d2-2 | / | Unkown | |
| HY-160508 | NCX1-IN-1 | Inhibitor | / | Unkown |
| HY-160962 | SM1044 | / | Unkown | |
| HY-160998 | YM-344031 | Antagonist | / | Unkown |
| HY-161143 | Carbonic anhydrase/AChE-IN-2 | Inhibitor | / | Unkown |
| HY-161388 | NSCLC-IN-1 | Inducer | / | Unkown |
| HY-162000 | hCAIX/XII-IN-13 | Inducer | / | Unkown |
| HY-162005 | AChE-IN-48 | Inhibitor | / | Unkown |
| HY-162063 | hCAIX/XII-IN-9 | Inhibitor | / | Unkown |
| HY-162280 | PROTAC BTK Degrader-9 | / | Unkown | |
| HY-162331 | STING Degrader-1 | Degrader | / | Unkown |
| HY-162344 | Ir-CA | Inducer | / | Unkown |
| HY-162374 | ANO61 | Inhibitor | / | Unkown |
| HY-162375 | AF299 | / | Unkown | |
| HY-162521 | Antibacterial agent 215 | Inhibitor | / | Unkown |
| HY-162526 | HIV capsid modulator 2 | Modulator | / | Unkown |
| HY-162774 | GRP75-IN-1 | Inducer | / | Unkown |
| HY-163116 | Anti-inflammatory agent 67 | Inhibitor | / | Unkown |
| HY-163117 | Anti-inflammatory agent 68 | Inhibitor | / | Unkown |
| HY-163380 | CA/MAO-B-IN-1 | Inhibitor | 98.34% | Unkown |
| HY-164682 | AMD 3329 octahydrobromide | Inhibitor | / | Unkown |
| HY-164684 | Dichlorobenzamil | Inhibitor | / | Unkown |
| HY-165569 | AU-1421 | Modulator | / | Unkown |
| HY-166363S | Beraprost-d3 | / | Unkown | |
| HY-166562S | Levomepromazine-d6 hydrochloride | / | Unkown | |
| HY-167091 | (Rac)-Beraprost | / | Unkown | |
| HY-168320 | N-Stearoyltyrosine | Inhibitor | / | Unkown |
| HY-168603 | AChE/CA I-IN-1 | Inhibitor | / | Unkown |
| HY-168604 | CA Ⅱ-IN-1 | Inhibitor | / | Unkown |
| HY-169115A | (Rac)-PD0299685 | Ligand | / | Unkown |
| HY-169162 | hBChE-IN-3 | / | Unkown | |
| HY-169206 | PF-3166 | Inhibitor | / | Unkown |
| HY-169209 | CA-M11 | Inhibitor | / | Unkown |
| HY-169845 | Calcium Channel antagonist 6 | Antagonist | / | Unkown |
| HY-170424 | D-myo-Inositol-1,3,4,5-tetrakisphosphate potassium | / | Unkown | |
| HY-170541 | FUT8-IN-1 | Inhibitor | / | Unkown |
| HY-170551 | CA IX/VEGFR-2-IN-3 | Inhibitor | / | Unkown |
| HY-170558 | FW-1 | / | Unkown | |
| HY-170560 | AChE/hCA I-IN-1 | Inhibitor | / | Unkown |
| HY-170801 | Anticonvulsant agent 7 | Control | / | Unkown |
| HY-170893 | CAIX/CAXII-IN-4 | Inhibitor | / | Unkown |
| HY-171129 | EP055 | / | Unkown | |
| HY-172772 | Anti-PEDV agent 1 | Inhibitor | / | Unkown |
| HY-172899 | Carbonic anhydrase inhibitor 33 | / | Unkown | |
| HY-172950 | CAXII-IN-2 | Inhibitor | / | Unkown |
| HY-172964 | KIM-161 | / | Unkown | |
| HY-173194 | Carbonic anhydrase inhibitor 29 | Inhibitor | / | Unkown |
| HY-173321 | PAD4-IN-5 | Inhibitor | / | Unkown |
| HY-173618 | LQFM020 | / | Unkown | |
| HY-17404S | Cilnidipine-d7 | Inhibitor | / | Unkown |
| HY-174232 | EGFR/CA-IX-IN-1 | / | Unkown | |
| HY-174269 | HIV Capsid-IN-2 | Inhibitor | / | Unkown |
| HY-174835 | hCA-I/hCA-II-IN-1 | Inhibitor | / | Unkown |
| HY-175021 | HDAC-IN-91 | / | Unkown | |
| HY-175219 | CA-II/Dkk1-IN-1 | Inhibitor | / | Unkown |
| HY-175441 | Carbonic anhydrase activator 1 | Activator | / | Unkown |
| HY-175638 | Carbonic anhydrase-IN-35 | / | Unkown | |
| HY-175675 | P2Y1 antagonist 4 | / | Unkown | |
| HY-176021 | U-44069 serinol amide | / | Unkown | |
| HY-176041 | Troponin modulator 1 | / | Unkown | |
| HY-176147 | Apoptosis inducer 38 | Inducer | / | Unkown |
| HY-177091 | AS2795440 | Inhibitor | / | Unkown |
| HY-177296 | GPR40 agonist 8 | Agonist | / | Unkown |
| HY-177573 | Cholesteryl γ-aminobutyrate | / | Unkown | |
| HY-178030 | CAXII-IN-3 | / | Unkown | |
| HY-178144 | FPR2 agonist 5 | / | Unkown | |
| HY-178251S | L-Phenylalanine-d | / | Unkown | |
| HY-178437 | Bastadins-5 | / | Unkown | |
| HY-178475 | CA IX/GPX4-IN-1 | / | Unkown | |
| HY-178963 | Nav1.2-IN-2 | Inhibitor | 99.82% | Unkown |
| HY-179016 | Ferroptosis/apoptosis inducer-3 | / | Unkown | |
| HY-179022 | CAIX/CDK-2-IN-1 | / | Unkown | |
| HY-179034 | CAIX/XII-IN-16 | / | Unkown | |
| HY-179271 | CA/HDAC-IN-1 | Inhibitor | / | Unkown |
| HY-179387 | CXCR2-IN-3 | / | Unkown | |
| HY-179439 | Multi-kinase-IN-8 | / | Unkown | |
| HY-179530 | CA-II/TNAP-IN-1 | Inhibitor | / | Unkown |
| HY-179712 | As-CA11 | / | Unkown | |
| HY-180056 | CAII-IN-12 | / | Unkown | |
| HY-180165 | Antiallergic agent-5 | Inhibitor | / | Unkown |
| HY-180189 | Carbonic anhydrase-IN-37 | Inhibitor | / | Unkown |
| HY-180194 | SERCA2a activator 2 | Activator | / | Unkown |
| HY-180244 | P2L-003 | / | Unkown | |
| HY-18051 | CXL 017 | / | Unkown | |
| HY-180891 | Multitarget AD-IN-4 | Inhibitor | / | Unkown |
| HY-181087 | Anticancer agent 296 | / | Unkown | |
| HY-181587 | PDGFRA/CAIX/XII-IN-1 | 98.10% | Unkown | |
| HY-181684 | PDE5/CA-IN-1 | Inhibitor | / | Unkown |
| HY-181755 | Phenylaminojuglone AJ-2 | Inhibitor | / | Unkown |
| HY-182007 | CA IX-IN-5 | Inhibitor | / | Unkown |
| HY-182068 | NFI23 | Inhibitor | / | Unkown |
| HY-182252 | SAR296968 | Inhibitor | / | Unkown |
| HY-182472 | AL-38022A | Agonist | / | Unkown |
| HY-182514 | BMMP | 99.85% | Unkown | |
| HY-182551 | SR-12062 | Agonist | / | Unkown |
| HY-182662 | Polymer blocking agent CA2000 | / | Unkown | |
| HY-182662A | Polymer blocking agent CA4000 | / | Unkown | |
| HY-182736 | YM-344484 | / | Unkown | |
| HY-183206 | UR 8225 | / | Unkown | |
| HY-183283 | CAII-IN-15 | Inhibitor | / | Unkown |
| HY-183549 | Ferroptosis/apoptosis inducer-4 | Inducer | / | Unkown |
| HY-183590 | CAIX/XII-IN-17 | / | Unkown | |
| HY-183591 | CAIX/XII-IN-18 | / | Unkown | |
| HY-183760 | AChE/BChE-IN-37 | Inhibitor | / | Unkown |
| HY-184034 | Parethoxycaine | Inhibitor | / | Unkown |
| HY-184490 | BPR1M492 | Agonist | / | Unkown |
| HY-184559 | CAII-IN-16 | Inhibitor | / | Unkown |
| HY-184587 | Antibacterial agent 356 | / | Unkown | |
| HY-184656 | VEGFR/PDGFR/CA II-IN-1 | Inhibitor | / | Unkown |
| HY-184660 | BE21349 | Inhibitor | / | Unkown |
| HY-184759 | Methyl acetazolamide | Inhibitor | / | Unkown |
| HY-184789 | CAIX-IN-18 | Inhibitor | / | Unkown |
| HY-184792 | CA/PRAK-IN-1 | Inhibitor | / | Unkown |
| HY-184937 | COX-2/CA II-1 | Inhibitor | / | Unkown |
| HY-184938 | COX-2/CA II-2 | Inhibitor | / | Unkown |
| HY-186165 | KARI 101 | / | Unkown | |
| HY-186172 | KS0365 | Activator | / | Unkown |
| HY-186248 | BCS12 | / | Unkown | |
| HY-19025 | CV-159 | Antagonist | / | Unkown |
| HY-19044 | SKF 95601 | / | Unkown | |
| HY-19230 | DY-9760e | Inhibitor | / | Unkown |
| HY-19409 | AJG049 | Antagonist | / | Unkown |
| HY-204388 | TAK-137 | Agonist | / | Unkown |
| HY-34740S1 | Ethylmalonic acid-d5 | Inhibitor | 98.09% | Unkown |
| HY-44602 | Thioaspirine | Inhibitor | / | Unkown |
| HY-50876A | Daporinad hydrochloride | / | Unkown | |
| HY-70037S | Cinacalcet-d3 | Agonist | / | Unkown |
| HY-A0057AS2 | Gabapentin-d4 hydrochloride | Inhibitor | / | Unkown |
| HY-B0006CS | (R)-Carvedilol-d4 | Inhibitor | / | Unkown |
| HY-B0021S1 | Doxifluridine-d3 | Inhibitor | / | Unkown |
| HY-B0109AS1 | Dorzolamide-d5hydrochloride | Inhibitor | / | Unkown |
| HY-B0358AS | Flunarizine-d8 dihydrochloride | / | Unkown | |
| HY-B0380S1 | Trimebutine-d5 fumarate | / | Unkown | |
| HY-B0380S2 | Trimebutine-d3 hydrochloride | / | Unkown | |
| HY-B0549S | Flavoxate-d5 | / | Unkown | |
| HY-B0588AS | Brinzolamide-d5 hydrochloride | / | Unkown | |
| HY-B0596S | Taltirelin-13C,d3 | / | Unkown | |
| HY-B0684S1 | Iopamidol-d3 | / | Unkown | |
| HY-B1221S | Flufenamic acid-d4 | / | Unkown | |
| HY-B1726 | Phenacaine | Inhibitor | 99.68% | Unkown |
| HY-B1837AR | β-Cyfluthrin (Standard) | Inhibitor | / | Unkown |
| HY-CE01249 | CA-CoA | / | Unkown | |
| HY-D0121 | INDO 1 | / | Unkown | |
| HY-D0121B | INDO 1 pentasodium | / | Unkown | |
| HY-D0157 | ZnAF-2 | / | Unkown | |
| HY-D1424 | Coelenterazine hcp | / | Unkown | |
| HY-D1501 | Fura PE-3 potassium | / | Unkown | |
| HY-D1631A | Calcium green-5N hexapotassium | / | Unkown | |
| HY-D1636 | 5-Nitro BAPTA | / | Unkown | |
| HY-D1640 | 5',5-Difluoro BAPTA tetrapotassium | / | Unkown | |
| HY-D1643 | 5,5'-Dinitro BAPTA AM | / | Unkown | |
| HY-D1700 | Mag-indo-1/AM | / | Unkown | |
| HY-D1702 | Mag-Fura-2 tetrapotassium | / | Unkown | |
| HY-D1755 | Fluo-3FF AM | / | Unkown | |
| HY-D2952 | BOCA-1-BG | / | Unkown | |
| HY-D3030 | Concanavalin A-FITC | / | Unkown | |
| HY-D3031 | Concanavalin A-TRITC | / | Unkown | |
| HY-DY1055 | TSQ (solution) | / | Unkown | |
| HY-E70197 | Calpain-1 (pig) | / | Unkown | |
| HY-E70813 | CAMKK2 Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-E70856 | PKCθ Recombinant Human Active Protein Kinase | / | Unkown | |
| HY-E70949 | Protein Kinase C,Rat | / | Unkown | |
| HY-E71159 | 1,4-Lactonase | / | Unkown | |
| HY-E71164 | 1,5-Anhydro-D-fructose dehydratase | / | Unkown | |
| HY-E71168 | 1,6-α-D-Mannosidase | / | Unkown | |
| HY-E71616 | 2'-Phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase | / | Unkown | |
| HY-I0096S | Indole-2-carboxylic acid-13C | Inhibitor | / | Unkown |
| HY-N0043R | Ginsenoside Rd (Standard) | Inhibitor | / | Unkown |
| HY-N0215S13 | L-Phenylalanine-d1 | Antagonist | 99.5% | Unkown |
| HY-N0215S16 | L-Phenylalanine-13C-1 | / | Unkown | |
| HY-N0215S6 | DL-Phenylalanine-d5 hydrochloride | Antagonist | / | Unkown |
| HY-N0215S9 | L-Phenylalanine-13C9,15N,d8 | Antagonist | / | Unkown |
| HY-N0219R | Bicuculline (Standard) | Antagonist | / | Unkown |
| HY-N0392R | Polygalasaponin F (Standard) | Inhibitor | / | Unkown |
| HY-N10512 | Gangliotetraose | / | Unkown | |
| HY-N11887 | Linocinnamarin | Inhibitor | 99.14% | Unkown |
| HY-N1228 | Soyacerebroside I | / | Unkown | |
| HY-N12726 | Halociline | Inhibitor | / | Unkown |
| HY-N15735 | Cimicifugic acid D | Inhibitor | / | Unkown |
| HY-N15737 | Fukinolic acid | Inhibitor | / | Unkown |
| HY-N16525 | Muramine | / | Unkown | |
| HY-N17738 | Acetyljujuboside B | / | Unkown | |
| HY-N18114 | rel-(E)-6,7-Transdihydroxyligustilide | / | Unkown | |
| HY-N18121 | Taxinine A | / | Unkown | |
| HY-N18279 | Bulbocapnine | Antagonist | / | Unkown |
| HY-N18431 | Stellettamide A TFA | Inhibitor | / | Unkown |
| HY-N19827 | Monodesmoside saponin C | / | Unkown | |
| HY-N2359A | Chelerythrine hydroxide | / | Unkown | |
| HY-N2359S | Chelerythrine-d6 chloride | / | Unkown | |
| HY-N3729 | (-)-Denudatin B | Inhibitor | 97.88% | Unkown |
| HY-N6687A | Calcimycin hemicalcium salt | / | Unkown | |
| HY-N6687B | Calcimycin hemimagnesium | / | Unkown | |
| HY-N6687C | Calcimycin hemicalcium hemimagnesium | / | Unkown | |
| HY-N7594 | Senecionine acetate | / | Unkown | |
| HY-N8112 | Polygalasaponin LII | / | Unkown | |
| HY-NP164A | Concanavalin A-Cy5.5 | / | Unkown | |
| HY-NP164C | Concanavalin A-AF350 | / | Unkown | |
| HY-NP164D | Concanavalin A-AF405 | / | Unkown | |
| HY-NP164E | Concanavalin A-AF430 | / | Unkown | |
| HY-NP164H | Concanavalin A-AF532 | / | Unkown | |
| HY-NP164I | Concanavalin A-AF546 | / | Unkown | |
| HY-NP164J | Concanavalin A-AF555 | / | Unkown | |
| HY-NP164K | Concanavalin A-AF568 | / | Unkown | |
| HY-NP164M | Concanavalin A-AF680 | / | Unkown | |
| HY-NP164N | Concanavalin A-Cy3 | / | Unkown | |
| HY-NP164O | Concanavalin A-Cy5 | / | Unkown | |
| HY-NP224 | Carbohydrate antigen50 protein, human | / | Unkown | |
| HY-NP225 | Carbohydrate antigen199 protein, human | / | Unkown | |
| HY-P0033A | Argireline acetate | Inhibitor | / | Unkown |
| HY-P0221A | PACAP (1-38), human, ovine, rat TFA | Inducer | / | Unkown |
| HY-P10316 | CaMKI(299-320) | Modulator | / | Unkown |
| HY-P10328 | Vasoactive intestinal contractor | Inhibitor | / | Unkown |
| HY-P1075A | CALP3 TFA | Inhibitor | / | Unkown |
| HY-P1076 | CALP2 | Antagonist | / | Unkown |
| HY-P10773 | CTP-amiodarone | Inhibitor | / | Unkown |
| HY-P10805 | Capsid assembly inhibitor | Inhibitor | / | Unkown |
| HY-P10811 | Na+-Ca2+ Exchanger | Inhibitor | / | Unkown |
| HY-P10972 | GIP (22-51) human | / | Unkown | |
| HY-P11019 | IS4 | Antagonist | / | Unkown |
| HY-P11082 | APGW-amide | / | Unkown | |
| HY-P11205 | Cys-PKHB1 | Activator | / | Unkown |
| HY-P11252 | DOTA-CA-170 | Ligand | / | Unkown |
| HY-P11253 | DOTA-Bn-CA-170 | / | Unkown | |
| HY-P11405 | [D-Arg1,D-Trp5,7,9,Leu11]-Substance P | Antagonist | / | Unkown |
| HY-P11700 | AAPDARETA | / | Unkown | |
| HY-P11825 | APH-IN-1 | Inhibitor | / | Unkown |
| HY-P1247A | Calcineurin autoinhibitory peptide TFA | Inhibitor | / | Unkown |
| HY-P1250A | RFRP-3(human) TFA | Agonist | / | Unkown |
| HY-P1345 | TLQP-21 | Agonist | / | Unkown |
| HY-P1366A | des-Gln14-Ghrelin TFA | / | Unkown | |
| HY-P1437A | Neuropeptide S (Mouse) TFA | Agonist | / | Unkown |
| HY-P1479 | Calmodulin-Dependent Protein Kinase II (290-309) | / | Unkown | |
| HY-P2424 | Cholecystokinin-J | / | Unkown | |
| HY-P2722 | Bovine brain Calcineurin | / | Unkown | |
| HY-P3089 | Dendrotoxin K | Inhibitor | / | Unkown |
| HY-P3168 | Martentoxin | Inhibitor | / | Unkown |
| HY-P3187A | exo-β-1,4-xylosidase, Clostridium stercorarium | / | Unkown | |
| HY-P3187B | exo-β-1,4-xylosidase, Bacteroides ovatus | / | Unkown | |
| HY-P3316 | OSK-1 | Inhibitor | / | Unkown |
| HY-P3419A | PAMP-12 (unmodified) TFA | Agonist | / | Unkown |
| HY-P3679 | Neuropeptide Y (1-24) (human) | Activator | / | Unkown |
| HY-P3811 | Autocamtide-3 | / | Unkown | |
| HY-P3943 | Calmodulin Dependent Protein Kinase Substrate Analog | / | Unkown | |
| HY-P3944 | Calmodulin Dependent Protein Kinase Substrate | / | Unkown | |
| HY-P4368 | Z-APF-CMK | Inhibitor | / | Unkown |
| HY-P4397 | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin | / | Unkown | |
| HY-P5142 | ω-Hexatoxin-Hv1a | Inhibitor | / | Unkown |
| HY-P5154 | Tamapin | Antagonist | / | Unkown |
| HY-P5319 | MCaE12A | Activator | / | Unkown |
| HY-P5422 | Caloxin 3A1 | Inhibitor | / | Unkown |
| HY-P5869 | Kurtoxin | / | Unkown | |
| HY-P5870 | KTX-Sp2 | Inhibitor | / | Unkown |
| HY-P6008 | Myoregulin | / | Unkown | |
| HY-P6008A | Myoregulin TFA | / | Unkown | |
| HY-P6013 | wt hMLN | Inhibitor | / | Unkown |
| HY-RS01762 | CA1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01763 | CA10 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01764 | CA11 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01765 | CA12 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01766 | CA13 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01767 | CA14 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01768 | CA2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01769 | CA3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01770 | CA4 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01771 | CA5A Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01772 | CA5B Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01773 | CA6 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01774 | CA7 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01775 | CA8 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS01850 | CALY Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10524 | Pik3ca Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10525 | Pik3ca Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS10973 | PPP1CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS11023 | PPP3CA Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00026 | Semotiadil recemate fumarate | / | Unkown | |
| HY-W040028 | Cartap hydrochloride | Inducer | / | Unkown |
| HY-W069974 | Ca2+ -Langerin-IN-1 | / | Unkown | |
| HY-W1049761 | Ti-MUV-10(Ca) | / | Unkown | |
| HY-W127795 | Fluo-3 ammonium | / | Unkown | |
| HY-W250153A | Adenosine 3'-phosphate 5'-phosphosulfate lithium, hydrate | Antagonist | / | Unkown |
| HY-W272201 | Catechol diacetate | Inhibitor | / | Unkown |
| HY-W339833 | 1-Myristoyl-2-hydroxy-sn-glycero-3-phosphate sodium | / | Unkown | |
| HY-W403046A | D-myo-Inositol-4-phosphate monoammonium | Activator | / | Unkown |
| HY-W414824 | 3β,7β-Dihydroxy-5-cholestenoic acid | / | Unkown | |
| HY-W424792A | O-Desmethyl Brinzolamide hydrochloride | Inhibitor | / | Unkown |
| HY-W707161 | 4-Methyl-2-(1-piperidinyl)-quinoline-d10 | / | Unkown | |
| HY-W710915 | Aprindine hydrochloride-d10 | / | Unkown | |
| HY-W711474 | (-)-Menthol-d4 | / | Unkown | |
| HY-W721517 | Gabapentin-d10 | / | Unkown | |
| HY-W751362 | Cetiedil | Inhibitor | / | Unkown |
| HY-W783254 | C18 LPA | / | Unkown | |
| HY-W795960 | D-myo-Inositol 1,4,5-trisphosphate sodium salt | / | Unkown | |
| HY-W838171 | Tiaramide | / | Unkown | |
| HY-Z8176 | (Z)-Flunarizine | Inhibitor | / | Unkown |
| HY-101136 | Dealanylascamycin | Inhibitor | / | Unkown |
| HY-101360R | 1-EBIO (Standard) | Agonist | / | Unkown |
| HY-101669 | TDN345 | Antagonist | / | Unkown |
| HY-101685 | Iganidipine | Antagonist | / | Unkown |
| HY-101727 | Nexopamil racemate | / | Unkown | |
| HY-10341D | Fasudil mesylate | / | Unkown | |
| HY-108163 | SB-237376 free base | Antagonist | / | Unkown |
| HY-108984 | BBMP | / | Unkown | |
| HY-109559 | Pentetate calcium trisodium | / | Unkown | |
| HY-110091 | TRPV1 antagonist 9 | Antagonist | / | Unkown |
| HY-111281 | UK 39671 | / | Unkown | |
| HY-112794 | Topanol CA | 98.11% | Unkown | |
| HY-113723 | MRS2298 | Antagonist | / | Unkown |
| HY-115231 | ci-IP3/PM | / | Unkown | |
| HY-115767S | (±)-1,2-Diolein-13C3 | Activator | / | Unkown |
| HY-116072 | Antiarrhythmic agent-2 | Inhibitor | / | Unkown |
| HY-116143 | MAGL-IN-12 | Inhibitor | / | Unkown |
| HY-116191 | WJD008 | Inhibitor | / | Unkown |
| HY-116723 | CFMMC | Antagonist | / | Unkown |
| HY-117055 | Ro 18-3981 | Inhibitor | / | Unkown |
| HY-117982 | SKI2496 | / | Unkown | |
| HY-118835S | Zimeldine-d6 | / | Unkown | |
| HY-119884 | DC-120 | / | Unkown | |
| HY-121186S | Bevantolol-d7 hydrochloride | Antagonist | / | Unkown |
| HY-121253 | NAADP receptor modulator-1 | Inhibitor | / | Unkown |
| HY-121366 | Kadethrin | Inhibitor | / | Unkown |
| HY-121720 | L 657925 | Antagonist | / | Unkown |
| HY-121914 | (2-Chlorophenyl)diphenylmethanol | Inhibitor | 99.92% | Unkown |
| HY-123434 | PD-149164 | Agonist | / | Unkown |
| HY-126072 | (Rac)-GK563 | / | Unkown | |
| HY-126821B | Fluo-3 sodium | / | Unkown | |
| HY-129334 | Macrocalin B | Inhibitor | / | Unkown |
| HY-130358 | PDDHV | Activator | / | Unkown |
| HY-131764 | 2'-O-MB-cGMP sodium | Inhibitor | / | Unkown |
| HY-133614 | Dihydroisopimaric acid | Activator | / | Unkown |
| HY-134043 | Chlorthalidone Impurity G | Inhibitor | / | Unkown |
| HY-134368 | Ap3A | Inhibitor | / | Unkown |
| HY-135110A | Rp-8-Br-cGMPS | / | Unkown | |
| HY-135317C | Emavusertib tosylate | / | Unkown | |
| HY-135317D | Emavusertib mesylate | / | Unkown | |
| HY-135317E | Emavusertib maleate | / | Unkown | |
| HY-135317F | Emavusertib phosphate | / | Unkown | |
| HY-135478A | LY393615 free base | Inhibitor | / | Unkown |
| HY-13551C | Amsacrine isethionate | / | Unkown | |
| HY-13551D | Amsacrine lactate | / | Unkown | |
| HY-135556A | Norfluoxetine oxalate | / | Unkown | |
| HY-137162 | Dotarizine | Inhibitor | / | Unkown |
| HY-138035 | Tenellin | / | Unkown | |
| HY-141613A | Dioleyl phosphatidylserine | Activator | / | Unkown |
| HY-14477 | UPF-1035 | Inhibitor | / | Unkown |
| HY-145536 | α-D-Glucose-1-phosphate disodium tetrahydrate | 98.0% | Unkown | |
| HY-14656S2 | Diltiazem-d6 hydrochloride | Antagonist | / | Unkown |
| HY-149779 | RyR2 stabilizer-1 | Modulator | / | Unkown |
| HY-152051S | Mabuterol-d9 hydrochloride | Agonist | / | Unkown |
| HY-15466A | Izorlisib methanesulfonate | / | Unkown | |
| HY-157321 | hCAI/II-IN-7 | Inhibitor | 99.80% | Unkown |
| HY-161848 | TCP-MP-CA | Inhibitor | / | Unkown |
| HY-163660 | Carbonic anhydrase inhibitor 23 | Inhibitor | / | Unkown |
| HY-164090 | Adenosine 3'-phosphate 5'-phosphosulfate | Antagonist | / | Unkown |
| HY-164631 | EL20 | Inhibitor | / | Unkown |
| HY-167203 | AJG049 free base | Antagonist | / | Unkown |
| HY-168377 | Fluo-4 potassium | / | Unkown | |
| HY-168382 | 5R(6S)-EET | Agonist | / | Unkown |
| HY-168382A | 5S(6R)-EET | Agonist | / | Unkown |
| HY-168767 | CA IX-IN-3 | Inhibitor | / | Unkown |
| HY-16935S | Mavatrep-d6 | Antagonist | / | Unkown |
| HY-169780 | (S)-AMG-628 | Antagonist | / | Unkown |
| HY-171187 | Chlorzolamide | Inhibitor | / | Unkown |
| HY-171469 | SKP-451 | Agonist | / | Unkown |
| HY-172321 | Etheno-NAADP sodium | / | Unkown | |
| HY-17404S1 | Cilnidipine-d4 | Inhibitor | / | Unkown |
| HY-174685 | Human FLI1 mRNA | / | Unkown | |
| HY-174829 | 7,4'-Dimethoxy-3-hydroxyflavone | / | Unkown | |
| HY-180864 | CA12 modulator-1 | / | Unkown | |
| HY-183522 | Thiocoumarin | Inhibitor | / | Unkown |
| HY-183907 | Cicletanine | Inhibitor | / | Unkown |
| HY-50722B | NNC 55-0396 free base | Inhibitor | / | Unkown |
| HY-A0082S | Diphenidol-d10 hydrochloride | Antagonist | / | Unkown |
| HY-B0109AS | Dorzolamide-d3 hydrochloride | Inhibitor | / | Unkown |
| HY-B0109S | Dorzolamide-d5 | Inhibitor | / | Unkown |
| HY-B0493S | Niflumic Acid-d5 | Inhibitor | / | Unkown |
| HY-B0549AS | Flavoxate-d4 hydrochloride | / | Unkown | |
| HY-B0632B | (2R,3R)-Diltiazem hydrochloride | Inhibitor | / | Unkown |
| HY-B0632S2 | Diltiazem-d4 | Inhibitor | / | Unkown |
| HY-B0684S | Iopamidol-d8 | / | Unkown | |
| HY-D0110B | Fura-2 pentasodium | / | Unkown | |
| HY-D1608 | BODIPY FL Thapsigargin | Inhibitor | / | Unkown |
| HY-N0081A | (-)-Praeruptorin A | Inhibitor | / | Unkown |
| HY-N0724R | Mesaconitine (Standard) | Activator | / | Unkown |
| HY-N10754 | Aschantin | Inhibitor | / | Unkown |
| HY-N12164 | Linearmycin B | Inhibitor | / | Unkown |
| HY-N1369S1 | Menthol-d2 | Modulator | / | Unkown |
| HY-N13916 | Alternaric acid | / | Unkown | |
| HY-N14440 | Furaquinocin C | / | Unkown | |
| HY-N5123 | α-L-Rhamnose | / | Unkown | |
| HY-N7063S | Nerol-d2 | / | Unkown | |
| HY-N7063S1 | Nerol-d6 | / | Unkown | |
| HY-N9422 | Adenosine 3'-phosphate 5'-phosphosulfate triethylamine | Antagonist | / | Unkown |
| HY-N9554 | WIN-64821 | Antagonist | / | Unkown |
| HY-P2209 | Nummularine B | Inhibitor | / | Unkown |
| HY-RS19521 | Ppp3ca Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS20700 | Caly Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26016 | Ppp3ca Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27211 | Caly Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27691 | Ppp2ca Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W002006 | 6-Amino-1,3-dimethyluracil | / | Unkown | |
| HY-W1113135A | Carboxymethyl-β-cyclodextrin sodium salt, for capillary electrophoresis | / | Unkown | |
| HY-W150752 | Triphenylethylene | 99.86% | Unkown | |
| HY-W166106 | Bromoriluzole | Inhibitor | / | Unkown |
| HY-W250153 | Adenosine 3'-phosphate 5'-phosphosulfate lithium | Antagonist | / | Unkown |
| HY-W288025 | ALXR-agonist-6 | Agonist | / | Unkown |
| HY-W587689 | Juvenile hormone B 3 (mixture of diastereomers) | / | Unkown | |
| HY-W653978 | Cinacalcet-d4 hydrochloride | Agonist | / | Unkown |
| HY-W755295 | Mabuterol hydrochloride | Agonist | / | Unkown |
| HY-W778574 | BAPTA tetracesium | Inhibitor | / | Unkown |
| HY-W931056 | AMG-628 | Inhibitor | / | Unkown |
| HY-U00354 | CP-060 | Antagonist | / | Unkown |
Inhibitory Antibodies
(6)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99276 | Abagovomab | Inhibitor | 95.00% | Unkown |
| HY-P991649 | Anti-CA6 Antibody (huDS6) | 98.03% | Unkown | |
| HY-P991902 | NAV006 | Inhibitor | / | Unkown |
| HY-P992012 | CA1001 | Agonist | / | Unkown |
| HY-P992349 | DXL625 | / | Unkown | |
| HY-P990830 | Anti-MUC16 Antibody (VK8) | Inhibitor | / | Unkown |